ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0032692;negative regulation of interleukin-1 production;6.0;0.7866048967936545;0.7164227609869718;9.260799472366804;65.65969381209598;6.518977089658987;0.002197570862002862;0.6565011041187423;[IL10, GHSR, IL1R2, NR1H4, TNFAIP3, ARRB2, PML, NLRP12, CEACAM1, NLRP3]
GO:0007253;cytoplasmic sequestering of NF-kappaB;13.0;1.0;0.9625549647676366;9.628524252492122;578.6196231821564;7.8311634786251565;0.019365878064054164;0.8630410292508717;[NFKBIA, IL10, G3BP2, CCDC22]
GO:0032693;negative regulation of interleukin-10 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.943860283624253;0.002184000309729388;0.6782296504172152;[CD274, IL23A, PRG2, LILRB1, PDCD1LG2, FCGR2B, DLL1, JAK3]
GO:1904057;negative regulation of sensory perception of pain;8.0;1.0;0.875;9.628524252492122;66.32592190330784;9.083926447120524;0.0022198689166493682;0.839552420951524;[IL10]
GO:1901224;positive regulation of NIK/NF-kappaB signaling;8.0;0.9326813400603323;0.8413406700301662;9.571365838652174;238.82315740091596;5.572381008289503;0.007993196151321231;0.6599718239061428;[TNF, HAVCR2, IL18, ACTN4, GREM1, IL23A, IL1B, CHI3L1, TLR7, TLR6, TLR4, TLR2, NOD2, CCL19, CD14, TNFSF14, TNFRSF10B, EIF2AK2, NLRP12, CD27, IL18R1]
GO:0045765;regulation of angiogenesis;6.0;0.7043150770688792;0.675277851124584;8.817594036275793;44.93985318205118;4.1639455212923995;0.0015040964427611868;0.5360646801923071;[SPARC, PLXND1, SERPINE1, CXCL13, ETS1, AQP1, CDH5, C3AR1, PROK2, CYP1B1, HOXA5, PPP1R16B, GHSR, SEMA6A, PRKCB, CYBB, HSPG2, SFRP2, COL4A2, HGS, ADAM12, AGTR1, EPHA2, C5AR1, TWIST1, C3, HMOX1, PLCG1, TGFB2, JUP, PLK2, TNFSF12, CXCL10, IL6, ID1, NRP1, ECM1, CD40, ITGB2, TNFAIP3, FASLG, ADM, PRL, BRCA1, PIK3C2A, HHEX, STAB1, CTSH, ITGB8, EMILIN1, CD34, CCR3, CCR2, IL10, ANXA1, ANXA3, GAB1, EMP2, SIRT1, F3, DCN, GREM1, IL1A, CEACAM1, IL1B, CHI3L1, ENG, CX3CR1, SP100, PTGS2, THBS2, DLL1, THBS1, GPNMB, CXCR2, E2F2, SEMA4A, STAT1, TIE1, KLF4, SULF1, PML, LRG1, TEK, PF4]
GO:0051091;positive regulation of DNA binding transcription factor activity;11.0;0.811012628672052;0.8379352666656883;9.431813958246067;277.8307104044464;4.2636448815154875;0.00929874384583087;0.650471949850128;[CSF3, PHB2, TNF, CLU, ICAM1, PYCARD, AKT1, TNFSF11, TRIM25, PRKCH, PRKCB, BTK, PRKCQ, ADAM8, S100A9, S100A8, CARD11, BEX1, TNFRSF11A, PRKCZ, NHLH2, NLRP3, S100A12, FZD1, TGFB1, FZD2, JUP, EIF2AK2, NFKB1, NFKB2, FOSL1, IL6, COPS5, JMY, MYD88, CD40, ITGB2, CD36, IL10, MYOCD, EDN1, CHUK, ANXA3, DDX58, RIPK2, NFAM1, IL18, IRAK3, TRAF1, GREM1, PSMA6, IL1B, KIT, HCLS1, TLR6, TLR4, LTF, TLR2, NLRC4, NOD2, CD40LG]
GO:0050796;regulation of insulin secretion;9.0;0.8259837884571596;0.8092325194088689;9.533214072687796;205.48125160941495;4.61801832846594;0.006877272570246766;0.6324062972578516;[KCNG2, SLC2A2, ARRB1, TNF, HNF4A, CD38, FAM3D, SOX4, GHSR, PRKCE, IFNG, IL1B, CFTR, BLK, KCNA5, ITPR3, DPP4, TMEM27, CNR1, CCL5, NR1H4, FKBP1B, FOXA2]
GO:0001821;histamine secretion;8.0;0.7980440201809971;0.7740220100904985;9.303101852057495;92.71543055810072;7.8311634786251565;0.003103102022309413;0.7754860644832351;[LYN, ADCYAP1, EDN1, CSF2, BTK]
GO:0045892;negative regulation of transcription, DNA-templated;10.0;0.556709148698489;0.6935955862101648;8.520155788878647;1581.2569993850602;2.683669001811703;0.05292324873051003;0.5524839694169422;[SPI1, EHMT2, SLA2, PHB2, MYB, HOXA2, HOXA7, JUNB, MEF2A, MED1, MEF2C, HOXB4, HOXB3, ATF3, NEDD4L, GATA3, GATA1, PRDM16, HESX1, ELANE, FZD1, JUN, PLK1, FZD8, NR2F2, SNAI2, PKIG, EZH2, BTG2, HELLS, PAWR, PAX5, SIRT1, PAX2, AES, MMP12, ZEB1, TAL1, RARA, HCLS1, PLCB1, NR1I2, ASCL2, BTAF1, FLNA, STAT1, NR1H2, NR1H4, POU4F1, CENPF, FOSB, LGR4, CSF2, GMNN, TNF, DACH1, MEN1, TLE4, DNMT1, AEBP1, FOXO1, SBNO2, NACC2, ZNF423, WFS1, NFKB1, NFKB2, DAB2, BCL6, BCL3, CDK2, CIITA, FHL2, FASLG, FOXM1, HHEX, EMILIN1, RFC1, PEG3, XCL1, BIRC5, CEBPA, CEBPB, HDAC2, UHRF1, RBBP8, E2F1, E2F7, E2F8, PRRX1, KLF4, PML, KLF8, KLF5, DNAJA3, GFI1, IKZF1, UXT, ZNF608, EDNRB, DPF3, SOX7, SOX4, HNF1B, RUNX2, EREG, SFRP2, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H2, SUV39H1, IFNA2, PTPRK, BRCA1, BMI1, XPO1, CD38, CD36, HBZ, EDN1, PARP9, CBFA2T3, MDFIC, IL1B, DEPDC1, SP100, SATB2, RELB, PURA, RXRA, APBB1, CDX2, LILRB4, NEDD4, ARID4A, LOXL2, CHCHD3, BASP1, EOMES, CCNE1, TIMELESS, CALCA, TCF7, TGFB1, CBX4, VDR, CAV1, HMGA1, NR4A2, BMP2, NR4A3, UBA3, MXD1, CREBZF, HMGB2, MYOCD, KLF12, H2AFX, GREM1, IFNG, ELF3, IRF7, IRF8, FBP1, PFDN5, LEF1, AURKB, TBX21, SNCA, MEIS2]
GO:0045651;positive regulation of macrophage differentiation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;840.7838216260375;7.212124270218933;0.0281402778535103;0.7650689957573628;[LIF, HCLS1, TRIB1, PF4]
GO:0000060;protein import into nucleus, translocation;9.0;1.0;0.896240625180289;9.628524252492122;93.4429707305496;6.444869117505266;0.0031274521371376313;0.7258315315665724;[TGFB1, RANBP6, PHB2, TNF, NFKBIA, POLA2, BCL6, IFNG, BCL3, AKT1, RAN]
GO:0010536;positive regulation of activation of Janus kinase activity;11.0;1.0;0.9324289523296623;9.628524252492122;2488.7782735422925;7.8311634786251565;0.08329716906043155;0.8329150168128974;[GH1, IL23A, CCL5, IL6R]
GO:0032689;negative regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.343086423195323;0.002184000309729388;0.647506047256038;[IL10, CD274, CD96, IL33, NR1H4, LILRB1, INHBA, PDCD1LG2, GATA3, RARA, XCL1, PGLYRP1, TLR4, HAVCR2]
GO:0072108;positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis;8.0;1.0;0.875;9.628524252492122;682.945505833763;8.390779266560578;0.022857571469204727;0.8041048419030481;[LIF, PAX2]
GO:0007260;tyrosine phosphorylation of STAT protein;10.0;1.0;0.9152410118609203;9.628524252492122;339.94073760219794;7.57984905034425;0.011377510560744174;0.8028748447945538;[IL15, LIF, JAK3]
GO:2000251;positive regulation of actin cytoskeleton reorganization;9.0;1.0;0.896240625180289;9.628524252492122;130.7363647434596;6.8867018697843045;0.004375628472874139;0.7484268790654467;[NRP1, HCK, CSF3, FES, NTF3, STAP1, HCLS1, TEK]
GO:0045779;negative regulation of bone resorption;7.0;1.0;0.8509193652572005;9.628524252492122;83.00611842489866;7.292166977892469;0.002778140083024753;0.7238411236270654;[CALCA, IL6, INPP5D, TNFAIP3, CD38, CSK]
GO:0071803;positive regulation of podosome assembly;8.0;1.0;0.875;9.628524252492122;306.3544197830862;7.379178354882098;0.01025340672906212;0.7523715242355574;[CSF2, LCP1, TNF]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[CD86, CSF3, CD80, PIK3CD, ARRB2, TNF, FGF5, TNFSF11, CCR7, PDGFRB, PDGFRA, GPX1, IGFBP5, GAB1, IL18, F3, VAV1, EREG, BTC, LCK, KIT, CHI3L1, HCLS1, ADAM8, HBEGF, ENG, PDGFA, GATA3, THBS1, PIK3R5, CD19, FYN, CCL19, ICOS, TGFB1, CCL21, TRAT1, EGF, PTK2, KITLG, LIN28A, CD28, NOX4, TEK, HPSE]
GO:0050687;negative regulation of defense response to virus;7.0;0.8436909121759173;0.7727648213451592;9.488762310116963;278.1909978651217;6.599019797332524;0.009310802342902009;0.6883935445785896;[HTRA1, IFIT1, IL2RA, DHX58]
GO:0045429;positive regulation of nitric oxide biosynthetic process;8.0;1.0;0.875;9.628524252492122;658.6394256443023;6.166155715036245;0.02204406883931546;0.6903374900225189;[ITGB2, PTGS2, TNF, CLU, AIF1, ICAM1, KLRK1, AKT1, CD36, EDN1, AGXT2, KLF4, DNM2, IFNG, IL1B, PTX3, TLR6, TLR4]
GO:0033089;positive regulation of T cell differentiation in thymus;10.0;0.8933024483968273;0.861892236059334;9.577230958104572;998.0942985465404;7.292166977892469;0.03340531794580182;0.7881627702307852;[EGR3, VNN1, IL1B, IHH, ADAM8, IL7R, RASGRP1]
GO:0090312;positive regulation of protein deacetylation;9.0;0.8436909121759173;0.8180860812682478;9.500690880982237;445.87784815594415;6.686031174322154;0.014923130313768376;0.7381645703673706;[TGFB1, LRRK2, BCL6, IFNG]
GO:1903543;positive regulation of exosomal secretion;9.0;1.0;0.896240625180289;9.628524252492122;273.97956964224545;7.069023426578259;0.009169849630321672;0.757750811958709;[VPS4B, IFNG, HGS, SDC1]
GO:0097191;extrinsic apoptotic signaling pathway;6.0;0.8259837884571596;0.7361122068187242;9.223059144383958;51.05903939735586;5.277263957350204;0.0017089000984773794;0.5929998367869052;[FASLG, TNF, CASP2, IL6R, DCC, DAPK1, TNFRSF1B, IL1A, IFNG, IL1B, BCL2A1, CASP8AP2, IL33, TGFB2, TGFB1, SORT1, TNFSF12, G0S2, TNFRSF10B, INHBA, PML, BCL2, CD27, BCL2L1]
GO:0045787;positive regulation of cell cycle;5.0;0.5265193887476639;0.5535007062347522;7.230628979693751;42.184038669436575;3.8238302933926853;0.0014118618110960173;0.4857918708913159;[, CCNH, CCNF, CCNC, PHB2, CHEK1, AKT1, SOX4, MED1, PRKCE, TAS2R13, FLT3LG, MIF, EREG, BTC, KIF20B, CDCA5, TGFA, RACGAP1, RAD21, SFN, PLK4, CDT1, PLK2, CDC7, CDC6, IGF1, FOSL1, CD28, CDKN1A, FEN1, BTG2, KIF14, BRCA1, BRCA2, DLGAP5, IL10, EDN1, ANXA1, DUSP3, KIF23, CIT, IL1A, RAD51C, TAL1, IL1B, CKS2, RARA, PLCB1, PCNA, CXCR5, KCNA5, AIF1, RANBP2, RANBP1, SVIL, POU4F1, FAP, MAD2L1, CCNT2, CEP120, CTGF, NUSAP1, PDGFRB, CDC25C, CDC25A, CCNE2, CCNE1, CCNB2, CCNB1, ECT2, FAM83D, TGFB2, TGFB1, UBE2C, NDC80, NR4A3, CNOT3, CDK2, CDK1, GPSM2, CKS1B, NUP62, CASP2, CCNA2, PSRC1, TFDP1, ESPL1, DTL, SMARCD3, VPS4B, AURKB, AURKA, CDC45, E2F1, POC1A, E2F7, SH2B1, E2F8, SPAG5, EGF, MEIS2, PML, RPS6KB1, EVI2B]
GO:0045669;positive regulation of osteoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;169.86351353303945;5.734022359845919;0.005685178930713632;0.6163584827319739;[CEBPA, CEBPB, IFITM1, CYR61, IL6R, CTHRC1, MEF2C, JAG1, IGF1, RUNX2, IL6, BMP2, SFRP2, FAM20C, LTF]
GO:0042832;defense response to protozoan;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;69.6526388451159;6.832634648514029;0.0023312111388408135;0.6725415662651573;[IL10, CD40, ARG1, SLC11A1, DEFA1, CLEC7A, BCL3, IRF8, PF4]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[CSF2, IL5RA, TNF, FGF5, TNFSF11, MAP3K8, MEN1, PDGFRB, MEF2A, PDGFRA, MED1, MEF2C, MAP2K2, PAQR3, EREG, BTC, TRIB1, PDGFA, CSF2RB, RASAL2, IQGAP3, CSF2RA, RASGRP1, RASGRP4, SPTA1, MAP2K6, TGFB1, IGF1, PTK2, NFKB1, LAT, LRRK2, CTSH, CCR5, SPTAN1, JAK3, MAP4K1, CHUK, RIPK2, STRADB, IL18, GFRA3, SPTB, DUSP6, IL1B, KIT, IL3RA, SHANK3, HBEGF, CAMK2D, NOD2, IL2RG, NRAS, CCL5, CCL2, NCAM1, FYN, EGF, MAPK14, MAPK13, KITLG, IL2RA, IL2RB, TEK]
GO:0071392;cellular response to estradiol stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;338.1710882258028;6.221725566191056;0.011318281988697268;0.6412996473849828;[IL10, ABCB4, POU4F1, CCNA2, KIF18A, RUVBL2]
GO:0045672;positive regulation of osteoclast differentiation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;840.7838216260375;6.599019797332524;0.0281402778535103;0.7337148045016781;[CCR1, TMEM64, FOS, TNF, POU4F1, IFNG, IL23A, CA2, TNFSF11, IL17A]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[AKT1, JUNB, PRKCD, FPR1, GATA3, FLRT2, HMOX1, HLA-DQA2, HLA-DQA1, HLA-DRB4, FN1, COL1A2, HLA-DRB1, CDKN1A, LRRC4, TIMP1, JAK3, HLA-DPA1, ANXA1, SERPINB2, IFNGR1, GPR35, RIPK2, IFNGR2, BGN, FOS, SIRT1, F3, FCER2, ZEB1, PLCB1, HLA-DQB1, CCL13, LRRC19, PTAFR, PTGS2, ALOX5, STAT4, CCL19, CCL18, IL12RB1, IL12RB2, CCL23, CCL21, CCL20, STAT1, IL10RA, HLA-DPB1, PF4, CSF3, CSF3R, CSF2, F13A1, IL5RA, RORA, CXCL13, TNF, PYCARD, IGHG1, MAP3K8, IL13RA2, IL13RA1, IFNA14, CISH, IFNA16, IFNA10, CSF1R, TNFRSF11A, FOXO1, SOCS2, TNFRSF17, CD300LF, IFNA21, TNFRSF10C, TNFRSF10B, NFKB1, CXCL10, CXCL11, CXCL12, BCL6, LCN2, BCL2, HLA-DRA, MYD88, BCL2L1, CIITA, ITGAM, ITGB2, PIK3CD, FASLG, TNFSF13B, ITGAX, CHUK, TNFRSF1B, IL3RA, XCL2, XCL1, BIRC5, LCP1, BIRC2, BIRC3, CX3CR1, CEBPA, CEBPD, NOD2, IL2RG, CCL8, CCL7, CCL5, CCL4, IL21R, CCL2, CCL1, FYN, FCGR1A, FCGR1B, PML, KLF6, IL2RA, IL2RB, PTPN6, IL1RN, IFITM1, IFI30, IFIT1, IFIT3, IFIT2, ICAM1, TNFSF11, TRIM25, IL15RA, RSAD2, ACSL1, IL1R1, IL1R2, HLA-B, FLT3LG, HLA-C, MIF, HLA-A, HLA-F, HLA-G, EREG, HLA-E, IFI27, IL23A, EBI3, TWIST1, INPP5D, CCR10, CCR1, EGR1, TNFSF14, TNFSF12, TNFSF13, LIF, PPBP, SDC1, CD27, IFNA5, IFNA4, IFNA7, CD40, TNFRSF13B, IFNA2, IFNA8, CCR9, CCR7, CCR6, CD36, CCR5, CCR3, CCR2, IL10, SYK, IL15, IL18, GP1BA, GAB2, IL17RB, VAV1, HCK, IL1A, CEACAM1, IL1B, KIT, RHOU, SP100, CXCR5, IFI6, CXCR4, CXCR6, CXCR1, CXCR3, CXCR2, IL32, CD74, IL33, OSM, PODN, CD40LG, IL18R1, IL17A, CD86, CD80, MPL, IL18RAP, CCRL2, IL6R, PRTN3, CSF2RB, CSF2RA, TGFB1, VCAM1, ISG15, NFKBIA, IL6, IL7R, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, OASL, LMNB1, GHR, LRRTM4, MMP1, MMP2, IRAK3, MMP9, DCN, IFNG, OAS1, OAS3, LTA, IRF7, IRF8, LTB, CAMK2D, SAMHD1, NCAM1, MX2, SOD2, CD4, LTBR]
GO:0043011;myeloid dendritic cell differentiation;6.0;0.8933024483968273;0.7697715367885581;9.4949928598676;91.1712242271392;6.8867018697843045;0.003051418826107602;0.6753065664753021;[TGFB1, SPI1, CSF2, RELB, CAMK4, LTBR]
GO:0060707;trophoblast giant cell differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;42.294635617598914;7.292166977892469;0.0014155633914202197;0.6631627702307852;[PLK4, LIF, NR2F2, E2F7, E2F8]
GO:0050691;regulation of defense response to virus by host;7.0;0.8933024483968273;0.7975705894556142;9.474373572664863;72.38922322033065;6.166155715036245;0.0024228021551132095;0.6662568552797195;[TNFAIP3, IFIT1, IL12RB1, DDX58, STAT1, IL15, LILRB1, PARP9, MMP12, IL23A, IL1B]
GO:0060708;spongiotrophoblast differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;42.294635617598914;8.390779266560578;0.0014155633914202197;0.7193458537639684;[LIF, ASCL2]
GO:0010634;positive regulation of epithelial cell migration;8.0;0.7866048967936545;0.7683024483968273;9.383401794459138;242.52723865374625;4.901876304479318;0.00811716841739676;0.6256821821716325;[DOCK5, NRP1, NRP2, CD40, SPARC, ITGB3, PIK3C2A, ETS1, EPB41L4B, AKT1, CTSH, CCR6, EDN1, ANXA1, ANXA3, PRKCE, MMP9, SIRT1, IFNG, ADAM9, PFN1, HBEGF, GATA3, PTGS2, THBS1, EPB41L5, HMOX1, PLCG1, JUN, TGFB2, TGFB1, PLK2, VIL1, TEK]
GO:0031334;positive regulation of protein complex assembly;6.0;0.612588685250814;0.6294146552155515;8.094593892566166;105.21570715161425;4.251620688548686;0.0035214750303757575;0.5405483923231058;[CYFIP1, CSF3, CSF2, CXCL13, TNF, CLU, ICAM1, PYCARD, TCL1A, PRKCE, HNF1B, PFN1, TWIST1, TMEM27, NCKAP1L, VASP, CDT1, JUN, TGFB1, VIL1, FOSL1, FES, JMY, PLEK, LMOD1, CCR7, CD36, MMP1, HCK, PSRC1, IFNG, TAL1, IRF8, TLR6, LCP1, TLR4, CDH17, PAK1, GSN, CCL21, BIK, NR1H2, RPA1, RPA2, GTF2H1, PSMC6, RPA3, PSMC2]
GO:2001240;negative regulation of extrinsic apoptotic signaling pathway in absence of ligand;10.0;1.0;0.9152410118609203;9.628524252492122;570.2036429558796;6.221725566191056;0.019084202779771145;0.7334203466557586;[CX3CR1, CSF2, STRADB, IFI6, TNF, GATA1, IL1A, IL1B, CTNNA1, BCL2, AKT1, SNAI2, FYN, PF4, BCL2L1]
GO:1903672;positive regulation of sprouting angiogenesis;8.0;0.8653626801206646;0.8076813400603323;9.446202695698167;183.7504864323888;6.139487467954083;0.00614996341619065;0.6889736746265369;[IL10, PPP1R16B, GHSR, NRP1, ANXA1, PLK2, PTGS2, KLF4, PIK3C2A, DLL1, AGTR1, HMOX1]
GO:0042045;epithelial fluid transport;5.0;0.8933024483968273;0.736892236059334;9.34084218004034;24.0554433753243;7.697632086000634;8.051140412786058E-4;0.6838982747154925;[EDN1, EDNRB, CSF2, CFTR, AQP1]
GO:0002230;positive regulation of defense response to virus by host;8.0;1.0;0.875;9.628524252492122;73.08237040089334;6.599019797332524;0.0024460011674546805;0.712474179321389;[DDX58, STAT1, LILRB1, PARP9, IL23A, IL12RB1]
GO:0046888;negative regulation of hormone secretion;8.0;0.6393367784920305;0.6946683892460153;8.673012807464685;252.0215160505561;5.666199763507158;0.00843493333757307;0.6647697194109919;[FAM3D, GHSR, EDN1, LIF, OSM, INHBA, IL1B, FKBP1B]
GO:0043382;positive regulation of memory T cell differentiation;10.0;1.0;0.9152410118609203;9.628524252492122;1160.4929435196905;7.9853141584524145;0.038840654443761495;0.8236103492792612;[IL23A, IL12RB1]
GO:0002904;positive regulation of B cell apoptotic process;10.0;0.8436909121759173;0.837086467948879;9.466005322994347;154.91562423562246;8.67846133901236;0.00518488652815606;0.8590579283277371;[IL10]
GO:0010888;negative regulation of lipid storage;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;46.28121162512291;6.8867018697843045;0.001548990502706573;0.6753065664753021;[ABCA1, NR1H2, ITGB3, TNF, NFKBIA, IL6]
GO:0001938;positive regulation of endothelial cell proliferation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;87.3065775231622;5.277263957350204;0.0029220725788817177;0.6207988894539612;[NRP1, NRP2, ECM1, ITGB3, HMGB2, NRAS, AKT1, HMOX1, PLCG1, CCR3, IL10, PPP1R16B, GHSR, JUN, EGR3, ITGA4, ARG1, CAV2, TNFSF12, SIRT1, F3, NR4A1, BMP2, LRG1, CXCL12, AGTR1, TEK]
GO:0030595;leukocyte chemotaxis;6.0;0.6873818243518346;0.6668112247660618;8.768322987269011;62.06300720445581;4.857092701852345;0.002077192998052941;0.5715122592407831;[CXCL6, CXCL9, IL1RN, CSF3R, ITGB2, PIK3CD, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, CXCL16, LGALS3, EDNRB, PDE4B, TNFSF11, FFAR2, CCR7, CCR6, CCR5, IL6R, CCR2, IL10, CXADR, ANXA1, FCER1G, SYK, PDE4D, VAV1, CH25H, IL1B, KIT, XCL2, XCL1, ADAM8, S100A9, S100A8, CX3CR1, CCL13, CALCA, C5AR1, CXCR5, CXCR4, TNFRSF11A, CORO1A, CCL8, CXCR1, CCL7, NUP85, CCL5, CXCR3, CXCR2, CCL4, CCL2, S100A12, CCL1, NCKAP1L, CCL19, CCL18, CCR1, CCL23, TGFB2, CCL21, CCL20, AZU1, DEFA1, PPBP, CXCL10, CXCL11, IL6, PF4]
GO:0007050;cell cycle arrest;6.0;0.811012628672052;0.7286266269261705;9.292052015870908;55.61614271062087;4.7664383335842135;0.0018614222452456451;0.5668761906316916;[CDKN1A, DUSP1, STRADB, MSH2, IFNG, RRAGD, GAS1, KIF20B, PPP1R15A, CUL5, THBS1, APBB1, GAS2L1, MAP2K6, BARD1, TGFB2, TGFB1, CDKN2C, DHCR24, INHBA, PML, CDK6, FAP, JMY, CDKN3]
GO:0045727;positive regulation of translation;8.0;0.6634067003016617;0.7067033501508309;9.123968241739727;1032.6861465930526;5.104244793218563;0.03456307596927652;0.6360313160968547;[FMR1, TNF, SOX4, PPP1R15A, PTAFR, FAM129A, THBS1, RXRA, CCL5, UPF3B, IL6, LIN28A, RPS6KB1, BCL3, CD28, EIF3E, EIF3D]
GO:0032494;response to peptidoglycan;5.0;0.8653626801206646;0.7229223519212526;9.461470167828956;77.33766349313319;7.379178354882098;0.002588421997736798;0.6676125360964777;[IL6, RIPK2, C5AR1, CARD9, NLRP3, TREM2, IRAK3, NOD2]
GO:0038110;interleukin-2-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.379178354882098;0.00101047745553359;0.728290889492758;[SYK, IL2RA, IL2RB, IL2RG, JAK3]
GO:0038111;interleukin-7-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;6.832634648514029;0.00101047745553359;0.7003406189322132;[CISH, IL2RG, SOCS2, IL7R, JAK3]
GO:0050871;positive regulation of B cell activation;8.0;0.7436939687323844;0.7468469843661922;9.117698628726131;160.32529438548238;4.695669262696007;0.00536594331968482;0.6151367444652258;[, IGHM, CDKN1A, CD40, TFRC, TNFSF13B, IGHG1, TRBC1, CD38, MEF2C, SYK, FCRL3, ATP11C, MIF, MSH6, MSH2, BTK, IGHD, CARD11, NOD2, UNG, IGKC, INPP5D, TBX21, NCKAP1L, IGHA1, CD74, TGFB1, TNFSF13, MLH1, BST1, IL6, PTPRC, BCL6, CD28, BCL2, CD27, CD320]
GO:0051044;positive regulation of membrane protein ectodomain proteolysis;9.0;1.0;0.896240625180289;9.628524252492122;964.0127980139503;7.069023426578259;0.03226464079433516;0.757750811958709;[IFNG, IL1B, ADAM9, ADAM8, TNFRSF1B, TNF]
GO:0051045;negative regulation of membrane protein ectodomain proteolysis;9.0;1.0;0.896240625180289;9.628524252492122;966.2736676900156;7.697632086000634;0.032340310067742455;0.7898978880348613;[IL10, TIMP2, TIMP3, TIMP1]
GO:0001866;NK T cell proliferation;8.0;0.9326813400603323;0.8413406700301662;9.56398573135455;102.50086820772104;9.083926447120524;0.0034306118141200753;0.839552420951524;[IL15]
GO:0072540;T-helper 17 cell lineage commitment;8.0;1.0;0.875;9.628524252492122;46.25983793501841;7.9853141584524145;0.0015482751445338478;0.7833693374183408;[IL6, LY9]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[IFITM1, PRF1, ADARB1, IFIT1, IFIT3, IFIT2, PYCARD, HERC5, DHX58, TRIM25, IFNA14, RSAD2, IFNA16, RNASE6, RNASE2, IL23A, IFNA10, DDX60, NLRP3, IFNA21, EIF2AK2, ISG15, AZU1, DEFA1, CXCL10, IL6, PTPRC, BCL2, SERINC5, APOBEC3A, APOBEC3B, IFNA5, IFNA4, IFNA7, CXCL9, CD40, IFNA2, IFNA8, OASL, IFIH1, DDX58, PARP9, PLSCR1, IFNG, OAS1, OAS3, IRF7, TLR8, TLR7, ZMYND11, EXOC1, UNC93B1, SAMHD1, IL33, STAT1, MX2, CARD9, LILRB1, PML, F2RL1]
GO:0032800;receptor biosynthetic process;6.0;0.8259837884571596;0.7361122068187242;9.318369324188282;73.9644013438808;8.16763571524637;0.002475521949340158;0.7408135829017477;[IL10, ACHE, TNF]
GO:0072307;regulation of metanephric nephron tubule epithelial cell differentiation;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;122.78518948428719;7.8311634786251565;0.004109509792542791;0.7754860644832351;[YAP1, STAT1, LIF, PAX2]
GO:0060550;positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity;11.0;1.0;0.9324289523296623;9.628524252492122;315.71736046966464;9.777073627680469;0.01056677592774235;0.9324289523296623;[IFNG]
GO:0060552;positive regulation of fructose 1,6-bisphosphate metabolic process;8.0;1.0;0.875;9.628524252492122;179.13735624701934;9.777073627680469;0.005995566100433959;0.875;[IFNG]
GO:0030183;B cell differentiation;6.0;0.7307253602413294;0.6884829927108091;9.022388448921806;64.35544597283358;5.2552850506314295;0.0021539188605695985;0.5918758344751833;[IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, LYL1, HHEX, LGALS1, BLNK, JAK3, TPD52, IL10, CR2, IFNA14, ITGA4, IFNA16, NFAM1, ATP11C, MSH2, KIT, CDH17, CARD11, IFNA10, DLL1, CD79B, CD79A, PLCG2, NKX2-3, IFNA21, VCAM1, KLF6, CD40LG, BCL6, BCL3, FCGR2B, ITM2A]
GO:0060670;branching involved in labyrinthine layer morphogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;72.98998111856169;7.57984905034425;0.002442908981319996;0.710754145523778;[IL10, SPINT1, FZD5, ADM]
GO:0042100;B cell proliferation;6.0;0.8653626801206646;0.7558016526504768;9.387362195675234;50.60132884827668;6.166155715036245;0.00169358093831245;0.6384578026126634;[IFNA5, IL10, IFNA4, IFNA7, MEF2C, CR2, CD40, IFNA14, IFNA16, IFNA2, CD180, PRKCD, LEF1, IFNA8, HSPD1, CD79A, CD40LG, PTPRC, BCL2, IL7R, MS4A1, CARD11, IFNA21, IFNA10]
GO:0060559;positive regulation of calcidiol 1-monooxygenase activity;10.0;1.0;0.9152410118609203;9.628524252492122;1344.9571378328073;8.67846133901236;0.04501450502042472;0.8590579283277371;[IFNG, IL1B, TNF]
GO:0042102;positive regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;564.8543510249671;5.212725436212633;0.018905166792893686;0.6628196464047262;[CD86, TFRC, CD80, CD3E, TNFSF13B, PYCARD, IL6R, JAK3, ICOSLG, CCR2, HLA-DPA1, HAVCR2, ANXA1, SYK, RIPK2, IL15, IL18, PDCD1LG2, HLA-E, ZAP70, IL23A, IL1B, XCL1, PRKCQ, CARD11, CD274, BLM, HHLA2, EBI3, CD1D, CORO1A, AIF1, HLA-DMB, CCL5, NCKAP1L, CCL19, IL12RB1, VCAM1, LILRB2, IGF1, CD4, IL6, CD40LG, PTPRC, CD6, DNAJA3, IL2RA, CD28, HLA-DPB1, CD24]
GO:1901676;positive regulation of histone H3-K27 acetylation;12.0;1.0;0.9481203125901445;9.628524252492122;1488.212472397538;9.777073627680469;0.049809132146875434;0.9481203125901445;[LIF]
GO:1904706;negative regulation of vascular smooth muscle cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;80.8833163751231;6.8867018697843045;0.0027070918088165762;0.7031056191423581;[IL10, CNN1, MEF2C, CDKN1A, MYOCD, TPM1, HMOX1, SOD2]
GO:0042104;positive regulation of activated T cell proliferation;10.0;1.0;0.9152410118609203;9.628524252492122;649.8896198547563;6.599019797332524;0.021751220713853325;0.7527151911823093;[HHLA2, IL18, IGF1, PYCARD, IL23A, IL2RA, CD24, IL12RB1, IL6R, ICOSLG]
GO:0030857;negative regulation of epithelial cell differentiation;6.0;0.6634067003016617;0.6548236627409754;8.638125548464245;143.89713366415532;6.139487467954083;0.004816107564726769;0.6370939872166814;[YAP1, JAG1, STAT1, CAV1, DLL1, GRHL2, ZEB1, IFNG, FRZB, ID1, S1PR3, HOXA7, EZH2]
GO:0070233;negative regulation of T cell apoptotic process;10.0;0.8259837884571596;0.8282329060895002;9.370695143190021;155.57980234840144;6.7325511899570465;0.005207115971869279;0.7595439928109722;[BLM, SLC46A2, CCL5, CD27, PRKCQ, IL7R, JAK3]
GO:0045187;regulation of circadian sleep/wake cycle, sleep;5.0;0.7866048967936545;0.6835434602577475;9.176539128749065;32.83985241625097;6.781341354126479;0.0010991203064235503;0.6370391240755715;[CSF2]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[IL1RN, CSF3, CSF2, NCF1, SERPINE1, CXCL13, TNF, CTGF, CXCL16, FGF5, EFEMP1, PLAU, VSTM1, TNFSF11, FAM3D, EPHB2, PHLDA2, MED1, MEF2C, IFNA14, IFNA16, DAPK1, PRKCE, PRKCD, FLT3LG, MIF, EREG, BTC, ADCYAP1, SFRP2, IL23A, NBL1, IFNA10, CALCA, EBI3, TGFA, PDGFA, ADRB2, PDGFD, PDGFC, IFNA21, TGFB2, TGFB1, JAG1, TNFSF14, TNFSF12, TNFSF13, LIF, INHBA, PPBP, IGF1, GH1, CXCL10, CXCL11, IL6, BMP2, CXCL12, PNOC, OGN, CD320, FBN1, IFNA5, IFNA4, NRP1, CXCL6, IFNA7, CXCL9, IFNA2, SECTM1, CXCL1, FASLG, ADM, PRL, CXCL3, IFNA8, CXCL2, CXCL5, TNFSF13B, TIMP1, TNFSF12-TNFSF13, IL10, EDN1, IL15, PDE4D, IL18, GREM1, IL1A, IFNG, IL1B, LTA, XCL2, XCL1, LTB, SHANK3, HBEGF, CCL13, NLGN1, GRN, CLEC12B, RETN, TYMP, CCL8, TTR, GPNMB, CCL7, CCL5, NPY, CCL4, NTF3, SPP1, CCL2, CCL1, CCL19, CCL18, IL32, CMTM8, IL33, CCL23, CCL21, EGF, CCL20, OSM, KITLG, CD40LG, CMTM2, FCGR2B, PF4, IL17A]
GO:0008361;regulation of cell size;5.0;0.7763722522362496;0.6784271379790451;8.999915593069748;28.02071028012121;5.54296712308321;9.378279560736312E-4;0.5737086083097278;[PLEK, IQGAP3, AQP1, AKT1, SLC12A2, EDN1, SLC12A1, VAV1, XK, IL7R, SHANK3]
GO:0043687;post-translational protein modification;7.0;0.6467165523344657;0.6742776414244334;8.507933057105237;151.15475272427284;3.8799197600437285;0.005059013543235805;0.5493386422205575;[CCNF, LGALS1, PSMD3, SKP2, ESCO2, MXRA8, SPARCL1, SDC2, C3, FN1, TF, SERPINA1, TIMP1, F5, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, FAM20C, FSTL1, CST3, SPP1, PSMC6, PSMC2, NUCB1, DSCC1, TNC, MEN1, IGFBP5, CISH, APLP2, IGFBP3, FBXW2, PSMD14, CUL5, SOCS2, IGFBP7, NAE1, WFS1, IL6, COPS5, UBA3, CCDC22, UBE2M, FBN1, LAMC1, CYR61, VCAN, DTL, LAMB1]
GO:1904707;positive regulation of vascular smooth muscle cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;80.75549718811011;6.444869117505266;0.0027028138156570515;0.6805102716434839;[IL10, JUN, DNMT1, IGFBP5, MMP2, IGF1, MMP9, TNF, GNAI2, PAK1, NR4A3]
GO:0045079;negative regulation of chemokine biosynthetic process;8.0;0.9326813400603323;0.8413406700301662;9.597752593825367;841.3347014012318;8.67846133901236;0.02815871530382644;0.8188169164668168;[IL6, ELANE]
GO:0045191;regulation of isotype switching;9.0;0.7248374789738407;0.7586593646672094;9.398949810847622;201.80341602143696;6.375876246018314;0.0067541787229542785;0.722303232910233;[IL10, CD40, TGFB1, TFRC, TNFSF13, MLH1, UNG, MSH6, MSH2, BCL6, TBX21, CD28]
GO:0050777;negative regulation of immune response;5.0;0.5193749703860713;0.549928497053956;7.293149336675085;78.83017544275083;4.909539177224887;0.0026383750295169523;0.5413150737011212;[IFNA2, TNFAIP3, ARRB2, TNF, LGALS3, DUSP10, DHX58, CTLA4, IL13RA2, PGLYRP1, JAK3, CCR2, HAVCR2, IL10, CD96, CR1, ANXA1, GPX1, ARG1, CD300A, SERPINB9, IRAK3, HLA-G, HLA-E, MMP12, ADCYAP1, CEACAM1, XCL1, SERPING1, CLEC12B, NLRC3, SAMSN1, HLX, INPP5D, TBX21, HMOX1, A2M, LYN, IL33, TGFB2, TGFB1, NR1H2, LILRB1, COL3A1, PTPRC, BCL6, IL2RA, PTPN6, FCGR2B, IL7R]
GO:0050778;positive regulation of immune response;5.0;0.46069491669276497;0.5205884702073027;6.7568446276081096;78.39406295848602;3.1543373037306295;0.002623778737144363;0.45155396826539046;[, CYFIP1, TFRC, CLEC10A, SLA2, MYB, TRBC1, C3AR1, PGLYRP1, PRKACB, MED1, MEF2C, PRKCH, PRKCB, PRKCE, PRKCD, SERPING1, PRKCQ, CFB, CFD, CFH, HHLA2, PRKDC, CFI, FPR1, FPR3, FPR2, GATA3, THY1, CFP, PRKCZ, C2, C3, KLRK1, C7, PLCG2, NCKAP1L, S100A14, PLCG1, IGHA1, HLA-DQA2, HLA-DQA1, ELANE, LYN, HLA-DRB4, FZD5, HLA-DRB1, DENND1B, ITK, IFIH1, CTLA4, HLA-DPA1, HAVCR2, ANXA1, RIPK2, NFAM1, SIRT1, MMP12, FCER2, PLSCR1, RARA, TLR10, HLA-DQB1, PTAFR, UNG, NRAS, HLA-DMB, CCL19, IL12RB1, CARD9, NR1H4, HLA-DPB1, TNF, CLU, PYCARD, IGHG1, GRAP2, CD177, LAG3, CD180, MSH6, CLEC4A, CLEC4D, MSH2, ADAM8, CLEC4E, S100A9, S100A8, BLK, CD274, LY96, CLEC7A, IGLV1-44, CD300LF, MAP2K6, EIF2B3, BMX, NFKB1, PTPRC, BCL2, HLA-DRA, LAT, MYD88, ITGAM, ITGB2, PIK3CD, PTPN22, TNFSF13B, FCGR3A, CR2, CR1, CHUK, LCK, XCL1, LCP2, PIK3C3, C1S, UNC93B1, C1R, NLRC4, NOD2, CCL5, FYN, CSK, FCGR1A, FCGR2A, PTPN6, MNDA, CD247, FCGR2B, ICAM2, ICAM3, DHX58, ICOSLG, RSAD2, SLC11A1, HLA-B, HLA-C, MIF, HLA-A, HLA-F, HLA-G, EREG, HLA-E, IL23A, BTK, TXK, CD1E, CD1D, CD1C, CD1B, CD1A, CD79B, CD79A, CD19, INPP5D, CD14, PAG1, SH2D1A, TNFSF13, PTK2, MARCO, CD28, IGHM, CD40, CD3G, CD3E, CD3D, CTSS, MUC13, CD38, FFAR2, CTSG, CCR7, MUC15, CD36, CCR2, FCER1G, SYK, IL15, IL18, GAB2, PARP9, LIME1, VAV1, LAT2, TLR1, HCK, IL1B, IGHD, TLR8, TLR7, TLR6, TLR5, TLR4, TLR2, C1QB, C1QA, LILRA2, RELB, PAK1, IGKC, CD74, IL33, LILRB1, MLH1, F2RL1, C1QC, CD86, FCN1, CD80, TRAC, IL18RAP, IL6R, THEMIS, MUC3B, CARD11, C5AR1, DDX60, RASGRP1, STAP1, NLRP3, BTNL8, TGFB2, TGFB1, CAV1, CRTAM, NFKBIA, IL6, NR4A3, NFKBID, IGKV3-20, HMGB2, TNFAIP3, PDE4B, DDX58, MMP2, PDE4D, IRAK3, FGR, ZAP70, IFNG, LTA, IRF7, LTF, COLEC12, HSPD1, CNR1, HLX, TBX21, TRAT1, MAPK14, CD4, TNIP3]
GO:0045639;positive regulation of myeloid cell differentiation;7.0;0.7307253602413294;0.7162820453778652;9.186691500213083;278.20784311065285;5.311165509025885;0.0093113661381102;0.622532616383239;[CSF3, HMGB2, MPL, TNF, ETS1, CA2, TNFSF11, HOXA5, MED1, FOS, IFNG, IL23A, TAL1, HCLS1, TRIB1, LEF1, GATA1, INPP5D, NCKAP1L, CCR1, CD74, JUN, JAG1, STAT1, LIF, ISG15, INHBA, TMEM64, MAPK14, POU4F1, CD4, FES, ACIN1, EVI2B, PF4, IL17A]
GO:0060333;interferon-gamma-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.514393750639154;0.00101047745553359;0.6329257181104212;[CIITA, IFI30, OASL, ICAM1, TRIM25, HLA-DPA1, IFNGR1, IFNGR2, PRKCD, HLA-B, HLA-C, HLA-A, HLA-F, HLA-G, HLA-E, HCK, IFNG, OAS1, OAS3, IRF7, IRF8, HLA-DQB1, CAMK2D, SP100, PTAFR, NCAM1, FCGR1A, FCGR1B, HLA-DQA2, HLA-DQA1, HLA-DRB4, VCAM1, STAT1, PML, HLA-DPB1, HLA-DRA, HLA-DRB1]
GO:1903078;positive regulation of protein localization to plasma membrane;8.0;0.8436909121759173;0.7968454560879586;9.434368238051164;218.50214452761784;5.845247994956144;0.00731307013817619;0.6739262542938873;[LRP1, TREM2, AKT1, EPHB2, PLS1, PRKCH, PRKCE, RHOG, SORBS1, VIL1, IFNG, EPHA3, EPHA2]
GO:1901215;negative regulation of neuron death;6.0;0.7586651285174919;0.7024528768488905;9.05316010758856;58.54459561550999;4.545965010825883;0.001959434928535777;0.5556011746527726;[CSF3, AKT1, MEF2C, F2R, MSH2, ADAM8, NAIP, C5AR1, SLC30A10, CORO1A, HMOX1, FZD1, JUN, WFS1, NR4A2, NR4A3, BCL2, BCL2L1, NRP1, BTG2, LRRK2, KIF14, ARRB1, ARRB2, CHL1, CD34, IL10, SIRT1, CEBPB, LRP1, GPNMB, NTF3, CCL2, FYN, SNCA, GABRA5, SOD2, POU4F1]
GO:0048469;cell maturation;3.0;0.6954798709641801;0.5458602480722345;8.242229891372231;25.22197897315013;4.886724499458715;8.441569379239579E-4;0.4480276307483924;[CDKN1A, IHH, BRCA2, ROPN1L, FBXO5, HOXA5, HBZ, IL15, RUNX2, EREG, TAL1, BTK, FAM20C, CFTR, CEBPA, EPB42, GATA3, TYMS, CCNB1, CCL19, FZD5, CCL21, NR4A2, FEV, GNAQ, SLC26A8, PLP1, TRIP13, SLC26A3]
GO:0060334;regulation of interferon-gamma-mediated signaling pathway;8.0;0.8933024483968273;0.8216512241984136;9.510741216835738;117.87544056254812;6.558197802812269;0.003945184914619341;0.7103865406232063;[MED1, ARG1, IFNGR1, STAT1, NR1H2, IFNGR2, TXK, PARP9, IFNG]
GO:0045637;regulation of myeloid cell differentiation;6.0;0.620063164412167;0.633151894796228;8.465373442686442;67.16582126229967;4.39257856489138;0.002247979592334476;0.5477569846744829;[CSF3, CSF3R, SPI1, CSF2, ITGA2B, MPL, TNF, ETS1, LGALS3, HOXA9, GPR171, TNFSF11, HOXA7, HOXA5, MED1, LHCGR, MEF2C, PRKCB, TYROBP, IL23A, PRKCQ, TRIB1, MYL9, GATA1, INPP5D, NCKAP1L, LYN, CCR1, NFE2, JUN, JAG1, LIF, ISG15, INHBA, NFKBIA, NR4A3, MAFB, CDK6, FES, FBN1, HMGB2, CA2, KLF13, GP1BA, FOS, NME1, CEACAM1, IFNG, TAL1, RARA, IRF7, HCLS1, TLR4, LTF, CEBPB, LEF1, DLL1, THBS1, CD74, STAT1, LILRB1, TMEM64, LILRB3, MAPK14, MEIS2, POU4F1, LILRB4, CD4, MEIS1, CAMK4, ACIN1, EVI2B, PF4, IL17A, C1QC]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[CD86, CXCL6, CXCL9, CD40, IL1RN, CSF3, CSF2, CD80, GFI1, SERPINE1, HMGB2, TNFAIP3, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, ICAM1, PYCARD, EDNRB, PDE4B, CTSG, CD36, CCR5, HAVCR2, IL10, GHSR, MEF2C, ARG1, PDE4D, CD180, PDCD1LG2, TNFRSF1B, IL1B, RARA, ADAM9, IRF8, TLR4, CX3CR1, CD274, CEBPB, CEBPE, SBNO2, KLRK1, STAP1, NLRP3, CCL2, CD14, ABCA1, CCL20, NR1H2, DEFA4, NR1H4, LILRB1, DEFA1, LILRB2, PPBP, MAPK14, NFKB1, CXCL10, CXCL11, IL6, TNIP3, PF4]
GO:0035729;cellular response to hepatocyte growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;78.10713999468214;7.138016298065211;0.00261417568375975;0.6881587980249038;[IL10, VIL1, NRP1, MED1]
GO:0042130;negative regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;581.9323154417883;5.734022359845919;0.01947675089275457;0.6894787953221185;[CD86, CD274, CEBPB, CD80, IHH, LRRC32, GPNMB, CTLA4, HAVCR2, IL10, TGFB1, ARG1, PAWR, LILRB1, PDCD1LG2, LILRB2, HLA-G, IL2RA, XCL1, PTPN6, PDE5A, MAD1L1]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[, CLEC10A, ADARB1, SLA2, HERC5, LGALS3, TRBC1, DHX58, TRIM25, PGLYRP1, RNASE6, RNASE3, MIF, HLA-E, SLPI, IL23A, BTK, SERPING1, PADI4, TRIM10, NAIP, CFB, CFD, CFH, PRKDC, TXK, CFI, GATA3, CD1D, CFP, LY9, C2, C3, KLRK1, C7, SLAMF7, S100A12, CD14, IGHA1, SLAMF1, LYN, SIGLEC16, KIR2DS1, KIR2DS2, SH2D1A, KIR2DS4, KIR2DS5, EIF2AK2, PTK2, MARCO, VNN1, APOBEC3A, APOBEC3B, IFNA5, IFNA4, IGHM, ITK, IFNA7, IFNA2, IFNA8, IFIH1, JAK3, CAMP, HAVCR2, ANXA1, FCER1G, SYK, ARG1, RIPK2, IL18, PARP9, TLR1, HCK, IGHD, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, C1QB, C1QA, LILRA2, LILRA5, RELB, IGKC, CARD9, NR1H4, KIR3DL1, F2RL1, LGR4, C1QC, FCN1, NCF1, NCF2, SLA, CLU, PYCARD, IGHG1, GRAP2, CLEC5A, CD177, IFNA14, IFNA16, CD180, MATK, CYBB, CLEC4A, CLEC4D, TYROBP, CLEC4E, S100A9, S100A8, IFNA10, BLK, CSF1R, LY96, DDX60, CORO1A, CLEC7A, NLRP3, IFNA21, TGFB1, DEFA4, LY86, DEFA1, BMX, NFKB1, NFKB2, FES, LCN2, KLRD1, SERINC5, ITGAM, KIR3DS1, CRISP3, HMGB2, PIK3CD, TREM2, TREM1, SIRPB1, PSTPIP1, CR2, CR1, CHUK, DDX58, FGR, ZAP70, LCK, IRF7, LTF, COLEC12, C1S, UNC93B1, C1R, HIST1H2BK, NLRC4, NOD2, FYN, CSK, MX2, GZMB, PML, GZMM, CD6, PTX3, PTPN6, CD244]
GO:0070373;negative regulation of ERK1 and ERK2 cascade;11.0;1.0;0.9324289523296623;9.628524252492122;1180.902522994834;5.6339389012889365;0.039523744701365535;0.7205488497465309;[PTPRR, FBLN1, ARRB1, DUSP10, TIMP3, CSK, EMILIN1, EPHB2, LYN, DUSP3, DUSP1, LIF, KLF4, DUSP6, NLRP12, TLR4, ATF3]
GO:0030838;positive regulation of actin filament polymerization;11.0;0.7866048967936545;0.8257314007264895;9.456673995565463;459.92540939869633;5.2552850506314295;0.01539328954657896;0.7011844742147011;[CYFIP1, CSF3, LMOD1, ICAM1, PYCARD, CCR7, PRKCE, HCK, PFN1, NCKAP1L, VASP, GSN, CCL21, VIL1, JMY]
GO:0035723;interleukin-15-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.212124270218933;0.00101047745553359;0.7197477358342742;[IL15RA, IL15, IL2RG, CD4, IL2RB, PLCB1, JAK3]
GO:0002827;positive regulation of T-helper 1 type immune response;8.0;0.8933024483968273;0.8216512241984136;9.503361109538115;171.8650643746189;6.943860283624253;0.005752169036102488;0.7301093378270707;[ANXA1, RIPK2, SLC11A1, CD80, IL18, IL23A, HLX, XCL1, CCL19, IL12RB1, IL6R, CCR2]
GO:0071345;cellular response to cytokine stimulus;5.0;0.6729672293956388;0.6267246265587396;8.214830917184116;61.59823360834823;3.805811787890007;0.0020616374440603005;0.48487040368196277;[PID1, TFRC, IFIT1, IFIT3, IFIT2, ICAM1, TCL1A, AKT1, TNFSF11, TRIM25, DAPK1, CDC34, BTK, PADI2, STXBP2, GATA3, ADAMTS12, ST3GAL6, EGR1, COL1A1, CD40, BRCA1, CCR7, HLA-DPA1, EDN1, MME, ARG1, SIRT1, HCLS1, TLR4, TLR2, CCL13, SELPLG, CXCR4, AIF1, CD58, CCL19, CCL18, IL12RB1, CCL23, GSN, CCL21, CCL20, STAT1, LAPTM5, POU4F1, NLRP12, ZYX, IL18R1, IL17A, CSF3, CSF2, ZFAND6, RORA, PYCARD, TLE4, POSTN, PCOLCE, KMO, KIF16B, CSF1R, CALCA, TCF7, CSF2RB, CORO1A, SBNO2, VCAM1, NFKB1, BSPRY, ALAD, MYBL2, CHUK, ITGA4, IL3RA, XCL2, CHI3L1, XCL1, IRF8, MCM2, CEBPA, CEBPB, LEF1, THBS1, CCL8, CCL7, CCL5, SPOCK2, CCL4, CCL2, CCL1, MAPK14, KLF4, PML, MAPK13, CD4, KLF5, RPS6KB1, IMPDH2, PTPN6, PTPN7, PTPN4, RBMX]
GO:0032695;negative regulation of interleukin-12 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;7.004484905440688;0.002184000309729388;0.6813299963962409;[IL10, LILRB1, IRAK3, ARRB2, THBS1, NFKB1, TLR8, TIGIT, JAK3, SLAMF1]
GO:0071902;positive regulation of protein serine/threonine kinase activity;11.0;0.6763753087927167;0.7706166067260205;9.206529842432747;1260.5827351979337;3.9422628906178643;0.04219056969626795;0.6340364598898325;[, IL1RN, CCNH, CCNC, TCL1A, AKT1, PROK2, TNFSF11, ACSL1, MIF, FPR1, TGFA, PDGFA, IQGAP3, PIK3R5, PDGFD, PDGFC, S100A12, ELANE, FZD5, GADD45B, FZD8, EIF2AK2, CDC6, IGF1, NOX4, CALM3, CD24, EZH2, CD40, MAP4K1, EDN1, SYK, RIPK2, SIRT1, DUSP6, MDFIC, IL1B, KIT, CKS2, TLR6, TLR4, CXCR4, PAK1, NTF3, CCL19, CD74, CD40LG, PKN1, CAMK1, CCNT2, TNF, MAP3K8, PDGFRB, MAP2K2, F2R, ADAM9, ADAM8, CSF1R, C5AR1, TNFRSF11A, ADRB2, RASGRP1, CCNB1, DRD4, MAP2K6, TGFB1, GH1, BMP2, CDK1, CSPG4, LRRK2, ARRB1, CKS1B, GHR, PSRC1, IFNG, PDE5A, LTF, NOD2, THBS1, CSK, SNCA, EGF, MAPK14]
GO:0035722;interleukin-12-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.948432231191374;0.00101047745553359;0.6551224661907153;[LMNB1, STAT4, IL12RB1, IL12RB2, IL10, SERPINB2, MIF, SOD2, IFNG, LCP1, PLCB1]
GO:0042536;negative regulation of tumor necrosis factor biosynthetic process;8.0;1.0;0.875;9.628524252492122;858.4851481575464;7.9853141584524145;0.0287327253223603;0.7833693374183408;[IL10, GHSR, BCL3, LILRB1]
GO:0014068;positive regulation of phosphatidylinositol 3-kinase signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;5.602686357784832;0.007979625599047746;0.6615216408886768;[CSF3, NCF1, PDGFA, CCL5, PDGFD, PDGFC, FYN, PDGFRB, PDGFRA, TGFB2, F2R, IL18, IGF1, SIRT1, PTK2, DCN, FGR, SELP, GH1, NEDD4, KIT, CD28, HCLS1, F2RL1, PTPN6, TEK]
GO:0033141;positive regulation of peptidyl-serine phosphorylation of STAT protein;11.0;1.0;0.9324289523296623;9.628524252492122;940.2079225453168;6.781341354126479;0.03146791303539702;0.7792270645443136;[IFNA5, IFNA4, IFNA7, IFNA14, IFNG, IFNA16, IFNA2, LIF, IFNA8, IFNA21, IFNA10]
GO:0038155;interleukin-23-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.57984905034425;0.00101047745553359;0.738553198190834;[IL23A, STAT4, IL12RB1]
GO:0046697;decidualization;4.0;1.0;0.75;9.628524252492122;34.68251427445171;6.781341354126479;0.0011607925405295219;0.5967981122146513;[GHSR, VDR, LIF, SPP1, PTGS2, JUNB, MEN1, CTSB]
GO:0042531;positive regulation of tyrosine phosphorylation of STAT protein;11.0;1.0;0.9324289523296623;9.628524252492122;1230.2749798860389;5.618190544320798;0.04117619640118775;0.7197434780388068;[CSF1R, CD40, HDAC2, CSF2, IFNA2, GHR, CCL5, FYN, IL6R, LYN, IL15, LIF, IL18, OSM, IGF1, PARP9, GH1, IL6, IFNG, IL23A, KIT, HCLS1]
GO:0002875;negative regulation of chronic inflammatory response to antigenic stimulus;9.0;1.0;0.896240625180289;9.628524252492122;534.5316565980578;9.777073627680469;0.017890293499078287;0.896240625180289;[IL10]
GO:0032966;negative regulation of collagen biosynthetic process;6.0;1.0;0.8231203125901445;9.628524252492122;106.39829570052878;7.697632086000634;0.00356105520484733;0.7167775754447168;[CIITA, IL6]
GO:0032725;positive regulation of granulocyte macrophage colony-stimulating factor production;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;64.94897299966192;7.212124270218933;0.0021737836760178982;0.6919486831672181;[SYK, IL23A, DDX58, CD80, IL1B, IL18, RASGRP1]
GO:0071650;negative regulation of chemokine (C-C motif) ligand 5 production;7.0;1.0;0.8509193652572005;9.628524252492122;88.6386384946749;8.67846133901236;0.002966655460821204;0.7947362817240173;[IL10]
GO:0032729;positive regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;5.6339389012889365;0.002183412136085803;0.6112402100070131;[PTPN22, CD3E, TNF, PYCARD, PDE4B, IL6R, CCR2, HLA-DPA1, HAVCR2, RIPK2, SLC11A1, PDE4D, IL18, IL23A, IL1B, LTA, TLR8, IRF8, TLR7, TLR4, TXK, EBI3, RASGRP1, HSPD1, KLRK1, CD14, IL12RB1, IL12RB2, FZD5, CD2, BCL3, HLA-DPB1, IL18R1, CD244]
GO:0050715;positive regulation of cytokine secretion;9.0;0.6913464685778243;0.7419138594692012;9.0689084645567;549.4808578036607;5.03214149931722;0.0183906298100222;0.6535845754738829;[FCN1, ORM1, LRRK2, PTPN22, TNF, PYCARD, IFIH1, CLEC5A, FFAR2, CD34, HAVCR2, IL10, POSTN, CHUK, SYK, DDX58, RIPK2, F2R, MIF, IL17RB, MMP12, TLR1, FGR, IL1A, IL1B, IGHD, TLR8, CLEC4E, TLR4, TLR2, CD274, CSF1R, TWIST1, GATA3, NOD2, PRKCZ, RASGRP1, NLRP3, CD58, CCL19, CD14, IL33, FZD5, CRTAM, MAPK14, CD2, NLRP12, F2RL1, CD244, IL17A]
GO:0034105;positive regulation of tissue remodeling;5.0;0.7763722522362496;0.6784271379790451;9.089527751759436;42.28934747447766;6.375876246018314;0.001415386402028971;0.6163036195908642;[TFRC, SYK, VDR, IL15, IL18, TNFRSF11A, TMEM64, IL23A, CA2, SPP1, TNFSF11, ADAM8]
GO:0034465;response to carbon monoxide;4.0;0.9326813400603323;0.7163406700301662;9.4949928598676;53.4946181105019;8.390779266560578;0.0017904167261278442;0.6791048419030481;[IL10, DNM2]
GO:0032722;positive regulation of chemokine production;6.0;0.7140352122741334;0.6801379187272112;8.734706376470026;66.68357405504983;5.8067817141283475;0.002231839212302133;0.6200793994936333;[CSF1R, TWIST1, TNF, PYCARD, HMOX1, FFAR2, IL6R, HAVCR2, EGR1, CD74, IL33, POSTN, RIPK2, EIF2AK2, AZU1, MIF, ADCYAP1, IL1A, IL6, IL1B, TLR7, TLR4, TLR2]
GO:0050830;defense response to Gram-positive bacterium;7.0;1.0;0.8509193652572005;9.628524252492122;71.44439831434403;5.334422371190153;0.0023911797157970473;0.6237219733958743;[SEH1L, HIST1H2BK, C5AR1, HMGB2, TNF, KLRK1, NLRP3, CD36, PGLYRP1, CAMP, HAVCR2, RIPK2, DEFA4, CARD9, RNASE6, RNASE3, DEFA1, LYZ, HLA-E, FGR, IL6, LTA, MYD88, TLR2]
GO:0014732;skeletal muscle atrophy;7.0;1.0;0.8509193652572005;9.628524252492122;61.03560093386372;7.697632086000634;0.0020428066347818368;0.7445766281117727;[RPS6KB1, IL15]
GO:0033138;positive regulation of peptidyl-serine phosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;5.152100814396198;0.026061291479152104;0.6787196871063318;[IFNA5, IFNA4, IFNA7, CSF3, IFNA2, ARRB1, ARRB2, IFNA8, TNF, TCL1A, AKT1, IFNA14, IFNA16, RIPK2, MIF, SFRP2, IFNG, HCLS1, IFNA10, PTGS2, PAK1, NTF3, IFNA21, SNCA, TGFB1, CAV1, LIF, OSM, IL6, BCL2, CAMK1]
GO:1904100;positive regulation of protein O-linked glycosylation;10.0;1.0;0.9152410118609203;9.628524252492122;1562.7491750944146;8.67846133901236;0.052303808507462586;0.8590579283277371;[IL15]
GO:0050728;negative regulation of inflammatory response;7.0;0.6729672293956388;0.6874029799550199;8.712233520617966;126.17514047852296;5.085725745451326;0.004222968401562039;0.6110036163900148;[TNFAIP6, TNFAIP3, RORA, ETS1, CDH5, DUSP10, PBK, PGLYRP1, IL10, GHSR, GPX1, IL1R2, PRKCD, TNFRSF1B, ADCYAP1, CALCRL, NLRC3, GATA3, NT5E, NLRP3, ELANE, NR1H4, KLF4, NFKB1, NLRP12, IL2RA, TEK, FCGR2B]
GO:0000902;cell morphogenesis;4.0;0.6260725219892441;0.563036260994622;7.923776160253697;43.26261951924051;4.420487353008457;0.0014479609414792109;0.47606392880653703;[CYFIP1, COL12A1, LST1, IHH, SPINT2, ANTXR1, CLU, CDH5, C1GALT1C1, CDH3, POF1B, CDH1, MED1, MEF2C, ACTN1, COL23A1, CLDN3, ADAM8, EPHA2, SLC1A3, EPB41L5, NCKAP1L, ECT2, ST14, TGFB2, BCL11B, VDR, FN1, PARVB, BCL6, ID1, NOX4, IL7R, NRP1, COL14A1, ITGB3, KIF14, LAMC1, ITGB7, ITGA4, STRADB, GP1BA, GREM1, PALLD, COL6A2, CDH11, COL6A1, COL6A3, CDH17, YAP1, LEF1, PDPN, SLITRK6, FLNA, LAMB1, MAPK14, GRHL2, TEK]
GO:0050729;positive regulation of inflammatory response;7.0;0.657518819034173;0.679678774774287;8.587070377663961;125.85203775116636;4.973052582947213;0.0042121544440509905;0.6052415056197167;[SERPINE1, TNF, ETS1, TNFSF11, FFAR2, CCR7, CCR2, TGM2, FCER1G, IL15, IL18, IL17RB, IL23A, IL1B, BTK, AGTR1, LTA, TLR10, TLR7, ADAM8, TLR6, TLR4, S100A9, S100A8, TLR2, SUCNR1, TNFRSF11A, NOD2, PTGS2, PLA2G7, C3, CNR1, CCL4, S100A12, CCL18, SNCA, IL33, CCL23, OSM, MAPK13, NFKBIA, NLRP12, IL6, CD6, CD28, MYD88, IL17A]
GO:0045930;negative regulation of mitotic cell cycle;6.0;0.5833093054345528;0.6147749653074209;7.836764783264067;61.236897459641845;4.271742091748107;0.0020495438483445192;0.5415774018184651;[ZWILCH, BUB1B, TNF, PTTG1, CHEK1, KNTC1, SOX4, TIPIN, CDC25C, MSH6, MSH2, AURKAIP1, MAD1L1, BLM, PRKDC, CCNB1, NACC2, RAD21, SFN, NAE1, CLSPN, FANCI, CDT1, TGFB1, PLK2, PLK1, CDC6, ZWINT, BCL6, CNOT3, CDK2, CDK1, BCL2, PTTG3P, EZH2, BCL2L1, TOP2A, CDKN1A, BTG2, BRCA1, TIMP2, CASP2, TOPBP1, IL10, DUSP1, TFDP1, GAS1, PCNA, TTK, AURKB, AURKA, GPNMB, E2F1, CCL2, BUB1, E2F7, E2F8, DONSON, RPA2, KLF4, PML, WEE1, CENPF, FAP, TRIP13, MAD2L1]
GO:0045019;negative regulation of nitric oxide biosynthetic process;8.0;1.0;0.875;9.628524252492122;660.5757278387367;7.292166977892469;0.022108875131204346;0.747921758369865;[IL10, CAV1, CD34]
GO:0032715;negative regulation of interleukin-6 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;64.96654663153603;6.166155715036245;0.002174371849661483;0.6384578026126634;[ORM1, TNFAIP3, PTPN22, NLRC3, ARRB1, ARRB2, TNF, INPP5D, NCKAP1L, CSK, HAVCR2, SLAMF1, IL10, GHSR, NR1H4, IRAK3, NLRP12, BANK1, BPI, TLR4]
GO:0097011;cellular response to granulocyte macrophage colony-stimulating factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;7.57984905034425;0.0027327542132076126;0.710754145523778;[CD4, CSF2, AKT1]
GO:0032834;positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response;13.0;1.0;0.9625549647676366;9.628524252492122;3627.31071452397;9.083926447120524;0.1214028252474149;0.9271073857191605;[IFNG]
GO:0032717;negative regulation of interleukin-8 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.943860283624253;0.002184000309729388;0.6782296504172152;[IL10, ANXA1, PTPN22, ARRB1, KLF4, BCL3, BPI, TLR6, ELANE]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[IFITM1, SPARC, LST1, SPINT2, ADARB1, PHB2, IFIT3, CYP1B1, EPHB1, SOX7, SOX4, MED1, MEF2C, HLA-G, EREG, SFRP4, SFRP2, SPINT1, BTK, TRIB1, GATA3, GATA1, BRIP1, INPP5D, HMOX1, SFN, S100A11, LYN, JUN, BCL11B, FZD5, LIF, EIF2AK2, CDC6, NR2F2, FOSL1, NOX4, SNAI2, SRPX, CDKN1A, BTG2, TNFRSF13B, TGFB1I1, ADM, PRL, PTPRK, BRCA2, LRRC32, HNF4A, TIMP2, CTLA4, CD33, HAVCR2, IL10, DUSP1, ARG1, IL15, PAWR, PDCD1LG2, CBFA2T3, NME1, IL1A, CEACAM1, ZEB1, IL1B, RARA, TLR2, PTGS2, ASCL2, AIF1, PAK1, GPNMB, FRZB, PDPN, CTNNA1, CCL23, CDKN2C, STAT1, OSM, LILRB1, LILRB2, PODN, SULF1, FAP, FABP7, DLC1, PKN1, CDKN3, CD86, CD80, SIRPG, IHH, TNF, ETS1, CDH5, DACH1, MEN1, IGFBP5, CD300A, IGFBP3, F2R, TPM1, TSC2, ADCYAP1, HGS, MAD1L1, CD274, CSF1R, CUL5, FBLN1, CNN1, NACC2, IGFBP7, TGFB2, TGFB1, RARRES3, CAV2, VDR, CAV1, HMGA1, DHCR24, INHBA, IL6, BMP2, CDK6, BCL6, OGN, BCL2, TNFAIP3, CXCL1, DUSP10, ADAMTS1, NUP62, PTGIR, MYOCD, KLF13, AXIN2, TGFBR3, GREM1, TFDP1, IFNG, ASPH, LTA, XCL1, PDE5A, CEBPA, CEBPB, NLRC3, DLL1, THBS1, CCL8, E2F1, CCL2, ZNF503, CSK, E2F7, KLF4, SOD2, PML, MEIS1, DNAJA3, IL2RA, PMP22, CD9, PTPN6, MNDA, FCGR2B]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[PID1, TFRC, MYB, HOXA3, AKT1, PROK2, MED1, MEF2C, PRKCH, CLDN7, AGTR1, PRKCQ, ATF3, HHLA2, PRKDC, PDGFA, IQGAP3, GATA1, PRKCZ, PDGFD, PDGFC, HMOX1, NCKAP1L, PLCG1, ELANE, LYN, MCTS1, JUN, FN1, CDC7, CDC6, FOSL2, FOSL1, NOX1, CDKN1A, ADM, HOXC10, TIMP1, JAK3, HLA-DPA1, HAVCR2, ANXA1, ARG1, RIPK2, FCRL3, EMP2, SIRT1, F3, PAX2, MMP12, RARA, HCLS1, HBEGF, PTAFR, KCNA5, PTGS2, NRAS, HLA-DMB, EPCAM, NTF3, FLNA, CCL19, IL12RB1, IL12RB2, STAT1, LRG1, HLA-DPB1, CSF3, CHRM1, CSF2, TNC, TNF, CTGF, FGF5, PYCARD, CDH3, PPP1R16B, IGFBP5, F2R, MSH6, ADCYAP1, CD274, CSF1R, BLM, DNMT1, CALCRL, TNFRSF11A, CORO1A, NACC2, CXCL10, CXCL12, PTPRC, CDK6, BCL6, CDK2, CDK1, BCL2, HPSE, BCL2L1, ITGB3, FASLG, ARRB1, FOXM1, CYR61, TNFSF13B, LBH, ITGA4, ASPM, XCL1, BIRC5, CX3CR1, HDAC2, SMARCD3, TTK, LRP2, NOD2, CCL5, E2F1, CTHRC1, PRRX1, PML, KLF5, PRC1, DNAJA3, IL2RA, PTPN6, CCNF, AQP1, CDC20, TCL1A, EDNRB, SKP2, TNS3, ICOSLG, SOX4, TIPIN, FLT3LG, MIF, RUNX2, EREG, HLA-E, BTC, SFRP2, IL23A, KIF20B, EBI3, TGFA, TWIST1, CD1D, PKHD1, SLAMF1, EGR1, EGR3, TNFSF12, TNFSF13, LIF, IGF1, PTK2, BST1, ID1, CD28, CD24, CD320, NRP1, NRP2, ECM1, CD40, CTSZ, KIF14, PRL, CD3E, BMI1, ESM1, RAC2, CTSH, CD38, CCR3, CCR2, IL10, EDN1, SYK, IL15, RHOG, IL18, PDCD1LG2, AVPR1A, GAB2, NME1, HCK, CEACAM6, IL1B, KIT, YAP1, AIF1, GNAI2, CST3, PURA, PAK1, CXCR2, CD74, CDX2, OSM, LILRB2, KITLG, CD40LG, CD86, CD80, SIRPG, MPL, IHH, ETS1, IL6R, TGM2, PDGFRB, GHSR, PDGFRA, MATK, CCNE2, CCNE1, PRTN3, CARD11, C5AR1, HTRA1, LTBP3, DPP4, CCNB2, CCNB1, TGFB2, TGFB1, VCAM1, CAV2, NR4A1, IL6, BMP2, LIN28A, NR4A3, IL7R, HMGB2, TNFAIP3, LAMC2, LAMC1, CXCL5, MYOCD, MMP2, GLP2R, TBC1D8, MMP9, TGFBR3, CCNA2, GREM1, ZAP70, IFNG, NDUFS4, LTA, LTF, LEF1, DLL1, THBS1, HLX, S1PR3, EGF, LAMB1, MAPK14, MEIS2, TSHR, CD4, CD6, RPS6KB1, TEK]
GO:0061515;myeloid cell development;4.0;0.811012628672052;0.655506314336026;9.022388448921806;32.15320660831846;5.9928839937622085;0.001076138889173156;0.5564763661386056;[CSF3, ARID4A, GATA1, TNFSF11, TSPAN2, NCKAP1L, MED1, BPGM, MEIS1, BCL6, TAL1, KIT, PTPN6, RHAG, EVI2B, TLR2]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPI1, SERPINE1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, JUNB, HOXA5, MEF2A, MED1, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, ATF3, HOXB5, PRKDC, GATA3, GATA1, RAD21, NKX2-3, JUN, JAG1, JUP, FZD5, FZD8, FOSL2, FOSL1, HOXC10, DLGAP5, RIPK2, PAX5, FOS, SIRT1, PAX2, MMP12, PLSCR1, ZEB1, TAL1, RARA, HCLS1, ENG, NR1I2, EPCAM, STAT4, STAT1, NR1H2, ATAD2, NR1H4, GTF2H1, POU4F1, PSMC6, PSMC2, FOSB, PF4, CSF3, CCNT2, PLXND1, RORA, TNF, RUVBL2, MEN1, ADCYAP1, FOXO1, SBNO2, NFKB1, NFKB2, CXCL10, COPS5, MAFB, MAFF, BCL3, CIITA, ARRB1, FOXM1, CYR61, HHEX, PPP1R12A, CHUK, PEG3, TFDP1, CEBPA, CEBPB, HDAC2, CEBPD, CEBPE, UHRF1, NOD2, ABLIM3, E2F1, E2F2, E2F5, E2F7, E2F8, PRRX1, KLF4, PML, KLF1, KLF6, KLF5, POU2AF1, CCNH, GFI1, CCNC, IKZF1, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, HNF1B, RUNX2, SFRP2, IL23A, BEX1, TXK, TWIST1, NHLH2, EGR1, EGR2, EGR3, BCL11B, LIF, IGF1, CD28, TOP2A, CD40, HNF4G, PRL, BRCA1, CD3D, HNF4A, IL10, EDN1, IL18, RGMA, IL1A, IL1B, TFEC, TLR4, TLR2, YAP1, SATB2, RELB, RXRA, APBB1, IL33, CDX1, OSM, LILRB1, GRHL2, F2RL1, CAMK1, FOXA3, IL17A, FOXA2, IHH, ARID4A, ARID4B, ETS1, HOXA10, EOMES, LMO2, ADRB2, NLRP3, TGFB2, TGFB1, VDR, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, BMP2, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYBL2, MYBL1, MYOCD, KLF13, DDX58, CKAP2, ETV1, DCN, GREM1, ELF3, IRF7, IRF8, TAF9, LEF1, DLL1, LUM, MAPK14, MEIS2, MEIS1, TNIP3, RBMX]
GO:0060302;negative regulation of cytokine activity;8.0;0.9326813400603323;0.8413406700301662;9.577230958104572;129.49867496184913;9.083926447120524;0.004334204109732123;0.839552420951524;[IL10]
GO:0001892;embryonic placenta development;5.0;1.0;0.7902410118609202;9.628524252492122;37.179255381886215;6.832634648514029;0.0012443562184742403;0.639662265535933;[MED1, CEBPA, CEBPB, CSF2]
GO:0002740;negative regulation of cytokine secretion involved in immune response;10.0;1.0;0.9152410118609203;9.628524252492122;981.2960148552594;7.9853141584524145;0.03284309450812846;0.8236103492792612;[IL10, LILRB1, TNF]
GO:0048661;positive regulation of smooth muscle cell proliferation;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;63.45804869205661;5.433268205826786;0.002123883781187112;0.6009779013089371;[TNF, MYB, AKT1, SKP2, IL6R, TGM2, PDGFRB, IL10, EDN1, IGFBP5, MMP2, IL18, MMP9, EREG, HBEGF, DNMT1, CALCRL, PTAFR, PTGS2, THBS1, AIF1, GNAI2, PAK1, CCL5, PDGFD, HMOX1, ELANE, JUN, STAT1, IGF1, IL6, NR4A3, RPS6KB1, NOX1]
GO:0032825;positive regulation of natural killer cell differentiation;9.0;0.9326813400603323;0.8625812952104552;9.59573442966913;802.2233332716177;7.697632086000634;0.02684969301047433;0.7898978880348613;[IL15, FLT3LG, RASGRP1]
GO:0051024;positive regulation of immunoglobulin secretion;9.0;1.0;0.896240625180289;9.628524252492122;579.4559284816147;7.379178354882098;0.019393868449801132;0.7736121494158466;[IL33, IL6, HLA-E]
GO:0030889;negative regulation of B cell proliferation;9.0;1.0;0.896240625180289;9.628524252492122;506.3396801226706;7.004484905440688;0.016946733417578675;0.7544503089863854;[LYN, IL10, TNFRSF13B, CD300A, PAWR, INPP5D, BTK, CTLA4, MNDA, PKN1, FCGR2B]
GO:0051384;response to glucocorticoid;7.0;0.7671156992804218;0.7344772148974115;9.223059144383958;62.73690238121479;4.800339885259895;0.00209974766315278;0.5964089702280253;[CDKN1A, IL1RN, SPARC, ADM, TNF, AQP1, ICAM1, ALAD, IL10, GHSR, EDN1, ANXA1, DUSP1, ANXA3, ARG1, CAD, AVPR1A, FOS, ADCYAP1, IL1B, ADAM9, ACSBG1, PCNA, FECH, ABCB4, PTAFR, PTGS2, TYMS, AIF1, FOXO1, IGFBP7, TGFB1, FOSL1, IL6, RPS6KB1, BCL2, ALPL, SDC1, FOSB]
GO:0048662;negative regulation of smooth muscle cell proliferation;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;63.58586787906956;5.970411137910149;0.0021281617743466354;0.6284474158353811;[CDKN1A, TNFAIP3, AIF1, CNN1, HMOX1, IL10, MEF2C, PTGIR, MYOCD, IGFBP5, IL15, IGFBP3, TPM1, KLF4, SOD2, IFNG, OGN, TRIB1]
GO:0051142;positive regulation of NK T cell proliferation;11.0;1.0;0.9324289523296623;9.628524252492122;1380.3051611134542;8.390779266560578;0.04619757154847237;0.8615337942327104;[IL23A, IL18]
GO:0070102;interleukin-6-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.138016298065211;0.00101047745553359;0.7159578506919597;[STAT1, IL6, IL6R]
GO:0032700;negative regulation of interleukin-17 production;6.0;0.8653626801206646;0.7558016526504768;9.427853557029971;65.25422870398782;7.292166977892469;0.002184000309729388;0.6960420709600095;[TGFB1, IFNG, NCKAP1L, TLR4]
GO:0032701;negative regulation of interleukin-18 production;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;64.96654663153603;9.083926447120524;0.002174371849661483;0.7876727335416686;[IL10]
GO:0030886;negative regulation of myeloid dendritic cell activation;7.0;1.0;0.8509193652572005;9.628524252492122;126.51759902192377;8.67846133901236;0.0042344301808169855;0.7947362817240173;[IL10, HAVCR2]
GO:0050731;positive regulation of peptidyl-tyrosine phosphorylation;10.0;0.7866048967936545;0.8085434602577476;9.446202695698167;779.3603785568229;4.60092389510664;0.02608449049149353;0.6505324738215158;[NRP1, CD40, CSF3, CSF2, NCF1, CD80, ITGB3, IFNA2, TREM2, ARRB2, CD3E, ICAM1, GHR, GRM5, CD36, IL6R, SYK, RIPK2, IL15, IL18, MIF, PARP9, EREG, GREM1, IFNG, BANK1, IL23A, KIT, HCLS1, HBEGF, CSF1R, HDAC2, TGFA, GATA1, CCL5, NTF3, STAP1, FYN, LYN, CD74, TGFB1, ACE, EGF, LIF, OSM, IGF1, GH1, CD4, IL6, CSPG4, CD24]
GO:0043410;positive regulation of MAPK cascade;10.0;0.6634067003016617;0.7469443620117512;9.174268980214526;1017.2390743488962;3.4929394666096676;0.03404607636272706;0.5938700986216354;[, IL1RN, PHB2, ICAM1, PROK2, TNFSF11, EPHB2, EPHB1, PRKCE, MIF, EPHA3, EPHA2, FPR1, TGFA, PDGFA, FPR2, SLC30A10, IQGAP3, PRKCZ, PIK3R5, PDGFD, PDGFC, S100A12, ELANE, SLAMF1, CCR1, JUN, FZD5, GADD45B, LIF, FZD8, EIF2AK2, IGF1, MARCO, NOX4, CD27, CD24, NOX1, EZH2, NRP1, CD40, TIMP2, CCR7, CD36, HAVCR2, MAP4K1, EDN1, GPR37, SYK, RIPK2, FCRL3, DUSP6, MDFIC, BANK1, IL1B, KIT, TLR6, PLCB1, TLR4, CCL13, CXCR4, GNAI2, PAK1, GPNMB, NTF3, CCL19, CCL18, CD74, CCL23, CCL21, CCL20, CARD9, OSM, CD40LG, F2RL1, PKN1, NCF1, TNF, CTGF, PYCARD, MAP3K8, PDGFRB, PDGFRA, MAP2K2, IGFBP3, F2R, ADCYAP1, ADAM9, ADAM8, CSF1R, C5AR1, TNFRSF11A, ADRB2, RASGRP1, PSAP, DRD4, MAP2K6, TGFB2, TGFB1, CAV2, GH1, IL6, BMP2, CDK1, CSPG4, LRRK2, TREM2, PTPN22, ARRB1, ARRB2, GHR, XCL2, CHI3L1, XCL1, PDE5A, NOD2, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CSK, EGF, TIE1, MAPK14, CD4, LTBR, TEK, FCGR2B]
GO:0048666;neuron development;4.0;0.6696747006330769;0.5848373503165385;8.088079211544972;32.15320660831846;4.814228997420562;0.001076138889173156;0.4961998948126311;[ROBO2, GABRB1, BTG2, FMR1, IHH, MEF2C, ETV1, THY1, NPY, TGFB2, FZD2, GABRA5, LIF, POU4F1, SLC4A7, UQCRQ, GNAQ]
GO:0001781;neutrophil apoptotic process;6.0;1.0;0.8231203125901445;9.628524252492122;45.60457565231589;9.083926447120524;0.0015263441056295624;0.7876727335416686;[IL6]
GO:0045835;negative regulation of meiotic nuclear division;8.0;0.7248374789738407;0.7374187394869203;9.271849308553389;325.6023743920082;7.212124270218933;0.010897618447788233;0.7438283705770736;[MSH2, LIF, TTK, FBXO5, TRIP13, BRCA2]
GO:0046013;regulation of T cell homeostatic proliferation;9.0;0.8933024483968273;0.8428918493787028;9.503361109538115;91.37297912534191;8.67846133901236;0.003058171380982827;0.8400575416471059;[IL2RA]
GO:0032819;positive regulation of natural killer cell proliferation;9.0;0.9326813400603323;0.8625812952104552;9.589303539338841;506.2743536675314;7.8311634786251565;0.016944546999915155;0.7967266896635242;[IL23A, IL15, IL18, FLT3LG]
GO:0001779;natural killer cell differentiation;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;64.35544597283358;7.474488534686424;0.0021539188605695985;0.7053660038532718;[IL15, PIK3CD]
GO:2000309;positive regulation of tumor necrosis factor (ligand) superfamily member 11 production;7.0;1.0;0.8509193652572005;9.628524252492122;85.21640127316344;9.083926447120524;0.0028521162608307568;0.8154717862087246;[IFNG, ADAM8]
GO:2000660;negative regulation of interleukin-1-mediated signaling pathway;8.0;1.0;0.875;9.628524252492122;306.2706419112467;8.16763571524637;0.010250602759086841;0.7926932703116032;[IL6, IL1RN, IL1R2]
GO:0051712;positive regulation of killing of cells of other organism;5.0;0.7192862368539868;0.6498841302879137;9.05316010758856;72.11799800547139;7.292166977892469;0.0024137244912587163;0.6631627702307852;[FCER2, IFNG, ARG1, PRF1, F2RL1, PGLYRP1]
GO:0071305;cellular response to vitamin D;8.0;1.0;0.875;9.628524252492122;396.2010793692189;7.379178354882098;0.013260493568666019;0.7523715242355574;[IL15, TNC]
GO:0018108;peptidyl-tyrosine phosphorylation;9.0;0.811012628672052;0.801746939516315;9.414950152194063;338.33129968976414;4.530049555519983;0.011323644122215096;0.627907570118429;[CSF2, IL5RA, SLA, SLA2, FGF5, EFEMP1, GRAP2, EPHB2, EPHB1, PDGFRB, PDGFRA, MAP2K2, PRKCD, MATK, EREG, BTC, MELK, BTK, EPHA3, EPHA2, BLK, CSF1R, TXK, CSF2RB, CSF2RA, MAP2K6, LYN, LIF, EIF2AK2, BMX, CLK4, PTK2, CLK1, FES, ITK, GHR, JAK3, SYK, RIPK2, IL15, FGR, ZAP70, HCK, LCK, KIT, IL3RA, HBEGF, TTK, FYN, CSK, IL12RB2, EGF, TIE1, WEE1, PTPN6, TEK]
GO:0034393;positive regulation of smooth muscle cell apoptotic process;9.0;0.9326813400603323;0.8625812952104552;9.56398573135455;127.00837127343294;7.212124270218933;0.004250855886408647;0.7650689957573628;[IFNG, ARRB1, SOD2]
GO:0032092;positive regulation of protein binding;5.0;0.7090535922965819;0.6447678080092112;8.529911963824013;32.707776742429765;5.311165509025885;0.0010946998524811438;0.5618542629869587;[NRP1, CSF3, PLXND1, LRRK2, ARRB1, MEN1, MEF2C, RIPK2, MMP9, LRP1, EPB41L5, CTHRC1, PLK2, CAV1, BMP2, RAN]
GO:1904894;positive regulation of STAT cascade;8.0;0.8653626801206646;0.8076813400603323;9.517298617381897;238.82315740091596;5.433268205826786;0.007993196151321231;0.6528575887187926;[CSF1R, CD40, HDAC2, CSF2, IFNA2, PRL, GHR, CCL5, CYP1B1, FYN, IL6R, LYN, IL15, F2R, LIF, IL18, OSM, IGF1, PARP9, GH1, IL6, IFNG, IL23A, KIT, HCLS1, IL7R]
GO:0048711;positive regulation of astrocyte differentiation;10.0;0.9326813400603323;0.8815816818910864;9.587702257971866;472.09912929902924;7.069023426578259;0.015800732996006494;0.7767511986393403;[BMP2, IL1B, LIF]
GO:0000018;regulation of DNA recombination;7.0;0.6056485694559711;0.6537436499851861;8.388833365564107;73.34977914704017;5.395046993006588;0.0024549510975359675;0.6268223193749;[CD40, TFRC, CHEK1, IL10, MSH6, MSH2, BLM, UNG, RAD51AP1, FIGNL1, TBX21, POLQ, TGFB1, TNFSF13, RPA2, MLH1, RAD50, RAD51, BCL6, CD28, IL7R]
GO:1903208;negative regulation of hydrogen peroxide-induced neuron death;10.0;0.9326813400603323;0.8815816818910864;9.596775554177542;1053.9315577462648;8.16763571524637;0.035274140760945843;0.8329342821725234;[IL10, NR4A3]
GO:0070091;glucagon secretion;9.0;1.0;0.896240625180289;9.628524252492122;103.34370176099773;9.777073627680469;0.003458820694647294;0.896240625180289;[IL6]
GO:0002675;positive regulation of acute inflammatory response;8.0;0.7090535922965819;0.729526796148291;8.971744716103052;164.518653823802;6.518977089658987;0.005506291286306897;0.7083807915285978;[FCER1G, OSM, TNFRSF11A, PTGS2, TNF, C3, IL6, CNR1, IL1B, BTK, TNFSF11, FFAR2, CCR7, ADAM8]
GO:0002437;inflammatory response to antigenic stimulus;5.0;0.7369933605727446;0.6587376921472925;8.866384200445225;27.85633247086267;6.343086423195323;9.323263787281718E-4;0.6146267465268138;[IL1RN, HMGB2, IL5RA, GATA3, TNF, RASGRP1, ICAM1, CD6, IL1B, IL2RA, CXCR2, ELANE]
GO:0043032;positive regulation of macrophage activation;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;126.59742726208806;6.641579411751319;0.004237101960174532;0.6905700452391912;[IL10, IL33, ITGAM, LRRK2, ITGB2, THBS1, HSPD1, STAP1, TLR6, TLR4, HAVCR2]
GO:2000676;positive regulation of type B pancreatic cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;129.82178199018807;8.390779266560578;0.00434501821119318;0.8253454670833372;[IL6, EIF2S1]
GO:0032760;positive regulation of tumor necrosis factor production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.9095484537234;5.587418885654044;0.002875315273172136;0.6366602269110988;[ORM1, LRRK2, CLU, PYCARD, IFIH1, CD36, CCR2, HAVCR2, FCER1G, DDX58, RIPK2, CYBB, MIF, HLA-E, TLR1, IL23A, TLR4, TLR2, HDAC2, PTAFR, LY96, TWIST1, NOD2, THBS1, RASGRP1, CCL19, CD14, FZD5, CARD9, AZU1, CD2, PF4]
GO:0030224;monocyte differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;69.52661413212034;7.004484905440688;0.0023269932051117304;0.6813299963962409;[CSF1R, MED1, MEF2C, JUN, CSF2]
GO:0030223;neutrophil differentiation;7.0;1.0;0.8509193652572005;9.628524252492122;48.172706276873754;8.390779266560578;0.0016122971264660058;0.7800242071602487;[CSF3, CSF2, LEF1]
GO:0030225;macrophage differentiation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;47.07409398820286;6.8867018697843045;0.0015755275618510598;0.6753065664753021;[CSF1R, CEBPA, CSF3, SPI1, CEBPE, MMP9, SIRT1, NKX2-3]
GO:2000553;positive regulation of T-helper 2 cell cytokine production;10.0;1.0;0.9152410118609203;9.628524252492122;874.8811381751227;7.9853141584524145;0.029281484352815565;0.8236103492792612;[IL6, RSAD2, NLRP3, XCL1, GATA3, PRKCZ]
GO:1900182;positive regulation of protein localization to nucleus;7.0;0.8436909121759173;0.7727648213451592;9.36615998802463;74.62336946219564;5.446340287394138;0.0024975770192273523;0.6294454608352614;[LRRK2, CDH1, AKT1, CCT3, CCT2, MED1, PRKCD, PARP9, IFNG, HCLS1, PTGS2, FYN, CCT8, CCT7, ECT2, CCT5, CCT4, TGFB1, JUP, PLK1, LIF, IGF1, MAPK14, CCT6A, CDK1]
GO:0090023;positive regulation of neutrophil chemotaxis;11.0;1.0;0.9324289523296623;9.628524252492122;945.710466239641;6.343086423195323;0.03165207822087823;0.7568146869955557;[CXCL6, CD74, EDN1, CCL21, C5AR1, CXCL1, PPBP, CXCL3, CXCL2, CXCL5, IL23A, IL1B, CXCR2, C3AR1, RAC2, XCL1, CCR7, NCKAP1L, CCL19, PF4]
GO:0034021;response to silicon dioxide;4.0;0.9326813400603323;0.7163406700301662;9.446202695698167;26.645441185012544;9.083926447120524;8.917989371221739E-4;0.714552420951524;[CSF2]
GO:0002690;positive regulation of leukocyte chemotaxis;9.0;0.7508913569872202;0.7716863036738992;9.33127272902419;423.36221235109986;5.288437257948329;0.014169552246136892;0.6666915524892495;[CXCL6, CXCL9, SERPINE1, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, C3AR1, RAC2, CCR7, CCR6, IL6R, CCR2, EDN1, IL23A, IL1B, XCL2, XCL1, C5AR1, FPR2, PLA2G7, THBS1, AIF1, CCL7, CCL5, CXCR2, CCL4, CCL1, NCKAP1L, CCL19, S100A14, CCR1, CD74, TNFSF14, CCL21, PPBP, MAPK14, CXCL10, CXCL11, IL6, CXCL12, F2RL1, PF4]
GO:0042742;defense response to bacterium;6.0;0.7866048967936545;0.7164227609869718;9.193206181234276;69.6526388451159;4.021331414093558;0.0023312111388408135;0.5287713881179241;[, SERPINE1, HP, CXCL13, TNF, MPO, PYCARD, IGHG1, TRBC1, PGLYRP1, IL6R, SLC11A1, PRKCD, RNASE6, RNASE3, HLA-E, CLEC4D, SLPI, IL23A, CLEC4E, S100A9, S100A8, SEH1L, C5AR1, CFP, KLRK1, NLRP3, S100A12, S100A14, IGHA1, ELANE, DEFA4, PRG2, ISG15, AZU1, DEFA1, PPBP, LYZ, SELP, IL6, BCL3, IGKV3-20, MYD88, IGHM, CXCL6, HMGB2, GNLY, STAB1, CTSG, CD36, CAMP, HAVCR2, IL10, FCER1G, SYK, ANXA3, RIPK2, TLR1, FGR, IGHD, LTA, IRF8, BPI, TLR6, TLR5, TLR4, LTF, TLR2, CEBPB, CEBPE, HIST1H2BK, NLRC4, NOD2, IGKC, CCL20, CARD9, NR1H4, CD4]
GO:0045580;regulation of T cell differentiation;8.0;0.5976175254657065;0.6738087627328533;8.663443356448536;131.165971977755;4.909539177224887;0.004390007040384596;0.626074061840201;[CD86, CD83, SLC46A2, CD80, IFNA2, IHH, DUSP10, MYB, CTLA4, HLA-DOA, JAK3, CR1, ANXA1, SYK, RIPK2, IL15, IL18, HLA-G, ZAP70, ZEB1, IFNG, IL23A, FANCD2, IL1B, RARA, ADAM8, CARD11, GATA3, PRKCZ, RASGRP1, HLX, TBX21, CLPTM1, NLRP3, NCKAP1L, CCL19, IL12RB1, CD74, TGFB1, EGR3, LILRB2, LILRB4, CD2, VNN1, BCL6, CAMK4, IL2RA, CD28, CD27, IL7R, NFKBID]
GO:0030217;T cell differentiation;6.0;0.657518819034173;0.651879722107231;8.679443697794976;65.04859315339479;5.132682728539097;0.00217711787291102;0.5856059460217904;[ITK, PIK3CD, CD3G, PTPN22, RORA, CD3E, CD3D, CCR9, CCR6, SOX4, EOMES, ANXA1, FCER1G, RSAD2, RHOH, RUNX2, VAV1, ZAP70, CLEC4D, LCK, CD8A, KIT, CLEC4E, BLM, PRKDC, TXK, LEF1, TCF7, GATA3, RELB, FUT7, TBX21, NKX2-3, EGR1, SEMA4A, TGFB1, BCL11B, FZD5, FZD8, BMX, CD4, PTPRC, MAFB, DNAJA3, BCL3, CD28, BCL2, IL7R, GPR18, IL18R1]
GO:0010508;positive regulation of autophagy;7.0;0.7192862368539868;0.710562483684194;9.040737587590003;216.89043707272492;5.132682728539097;0.007259127740103463;0.6134049986888465;[PLEKHF1, LRRK2, SESN3, DAPK1, RIPK2, TSC2, SIRT1, DCN, IFNG, ADRB2, FOXO1, HMOX1, PLK2]
GO:0007219;Notch signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.50247477320489;4.99795013456894;8.87013979980389E-4;0.5787157149004503;[TMEM100, HHEX, HNF1B, FCER2, MAML3, CEBPA, PSEN2, KCNA5, DTX3, DLL1, PLN, GMDS, PERP, S1PR3, ZNF423, TGFB1, JAG1, NR1H4, KRT19, BMP2, IL2RA, SNAI2]
GO:0044130;negative regulation of growth of symbiont in host;7.0;1.0;0.8509193652572005;9.628524252492122;102.69207226600344;7.212124270218933;0.0034370112418783067;0.7197477358342742;[IL10, LTA, IRF8, CTSG, CD36, TNF, MPO, ELANE]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, IQGAP3, GATA1, C3, JUN, JAG1, JUP, FN1, AZU1, NR2F2, COL1A1, LRRC32, HOXC10, DLGAP5, RIPK2, FOS, SIRT1, MMP12, PLSCR1, CKS2, PTAFR, STAT4, SPP1, STAT1, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, NCF1, RORA, CTGF, RUVBL2, ADCYAP1, PKP3, BLM, FOXO1, SBNO2, ZNF423, NFKB1, NFKB2, CXCL10, MYD88, CIITA, FHL2, PIK3CD, ARRB1, ARRB2, FOXM1, HHEX, ITGB8, PPP1R12A, PEG3, PPP1R15A, UHRF1, CCL5, E2F1, E2F2, E2F5, E2F7, E2F8, PRRX1, POU2AF1, EIF3E, EIF3D, CCNH, CCNC, IKZF1, TNFSF11, EPHB2, HNF1B, SFRP4, SFRP2, EGR1, EGR2, EGR3, IGF1, ID1, CD28, CD40, HNF4G, BRCA1, BRCA2, CD3E, CD3D, HNF4A, CTSH, CD38, CD36, CD34, IL10, IL18, RGMA, IL1A, IL1B, KIT, YAP1, SATB2, RELB, RXRA, CD74, IL33, OSM, FOXA3, IL17A, FOXA2, CD86, CD80, IHH, ETS1, ACTG2, EOMES, CCNE1, CCNB1, VDR, CAV1, HMGA1, INHBA, IL6, BMP2, NAT8, TCF4, IL7R, HMGB2, ARHGEF10L, LYL1, NUP62, MYBL2, MYBL1, YWHAH, MYOCD, DDX58, NCBP2, ETV1, ACTA2, CCNA2, GREM1, PSRC1, ELF3, IRF7, IRF8, CREB5, TAF9, RNF6, TBX21, RBM38, EGF, MAPK14, CD4, TNIP3, NAA15, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, MED1, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB5, PRKDC, NUP85, RAD21, PRDM16, NKX2-3, FZD1, NFE2, FZD2, FZD5, FZD8, UPF3B, FOSL2, FOSL1, TGFB1I1, PAWR, SERPINB9, PAX5, PAX2, ZEB1, TAL1, RARA, HCLS1, PLCB1, ENG, NR1I2, FAM129A, EPCAM, GSN, NR1H2, NR1H4, GTF2H1, POU4F1, PLP1, FOSB, PF4, CSF3, CSF2, PLXND1, FMR1, TNC, TNF, CLU, CDH3, CDH1, LAMP3, MEN1, MAP2K2, F2R, ADAM2, ADAM8, DNMT1, DAB2, COPS5, MAFB, MAFF, BCL3, CDK2, CDK1, PTPN22, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, CEBPA, CEBPB, HDAC2, SMARCD3, CEBPD, CEBPE, NOD2, ABLIM3, POLR2E, POLR2K, POLR2L, KLF4, PML, KLF1, KLF6, KLF5, GFI1, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, NIF3L1, IL23A, BEX1, TXK, TWIST1, NHLH2, BCL11B, LIF, TOP2A, IFNA2, PRL, EPB41L4B, EDN1, RHOG, PARP9, MDFIC, TFEC, TLR6, TLR4, TLR2, SP100, APBB1, CDX2, CDX1, LILRB1, GRHL2, CAMK4, F2RL1, CAMK1, ARID4A, ARID4B, HOXA11, HOXA10, LMO2, HGS, ADRB2, STAP1, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, LIN28A, NR4A3, FEV, SLC40A1, CKS1B, KLF13, CKAP2, AXIN2, DCN, DNM2, IFNG, LEF1, DLL1, THBS1, LUM, MEIS2, MEIS1, RPS6KB1, RBMX]
GO:0045582;positive regulation of T cell differentiation;9.0;0.7043150770688792;0.7483981637147287;9.320222892837606;861.1600055729926;5.395046993006588;0.0288222503928399;0.6721435792979885;[CD86, CD83, CD80, IHH, DUSP10, MYB, ANXA1, SYK, RIPK2, IL18, HLA-G, ZAP70, IFNG, IL23A, IL1B, RARA, ADAM8, GATA3, PRKCZ, RASGRP1, HLX, NLRP3, NCKAP1L, CCL19, IL12RB1, CD74, TGFB1, EGR3, LILRB2, LILRB4, VNN1, BCL6, IL2RA, CD27, IL7R, NFKBID]
GO:0001915;negative regulation of T cell mediated cytotoxicity;9.0;0.8933024483968273;0.8428918493787028;9.557065288509976;365.562885098783;7.9853141584524145;0.012235060779019208;0.8046099625986299;[CEACAM1, PTPRC, LILRB1, FCGR2B, IL7R]
GO:0010744;positive regulation of macrophage derived foam cell differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;113.85781812010546;7.004484905440688;0.0038107187070962377;0.6813299963962409;[MSR1, PRKCH, CSF2, AGTR1, IL18, CD36, NFKB1, PF4]
GO:0001916;positive regulation of T cell mediated cytotoxicity;9.0;0.8653626801206646;0.8289219652406215;9.523163736834295;365.14378084230765;6.518977089658987;0.012221033736724321;0.7296214167088868;[HLA-B, HLA-C, CD1E, CD1D, HLA-A, CD1C, HLA-F, CD1B, HLA-G, CD1A, HLA-E, IL23A, XCL1, IL12RB1]
GO:0032755;positive regulation of interleukin-6 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;64.94897299966192;5.395046993006588;0.0021737836760178982;0.5990232667078439;[IL1RN, TNF, PYCARD, IFIH1, CD36, IL6R, FCER1G, DDX58, RIPK2, F2R, EREG, TLR1, ADCYAP1, IL1A, IL1B, TLR8, TLR7, TLR6, TLR4, TLR2, PTAFR, TWIST1, NOD2, HSPD1, IL33, SIGLEC16, CARD9, LILRB2, MAPK13, IL6, F2RL1, MYD88, IL17A]
GO:0030212;hyaluronan metabolic process;7.0;0.8933024483968273;0.7975705894556142;9.510741216835738;101.21806367924876;6.280566066213989;0.0033876775010012305;0.6721078059595746;[TGFB1, IL15, HMMR, PKHD1, IL1B, AKT1]
GO:0033160;positive regulation of protein import into nucleus, translocation;10.0;1.0;0.9152410118609203;9.628524252492122;970.0189350156829;7.292166977892469;0.03246566079461078;0.7881627702307852;[MED1, IFNG, LRRK2, CDK1, IGF1]
GO:0045347;negative regulation of MHC class II biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;147.30203964950672;8.16763571524637;0.0049300667038400395;0.7686126355688037;[IL10, HDAC2, SPI1, PF4]
GO:0045589;regulation of regulatory T cell differentiation;9.0;0.7866048967936545;0.7895430735771163;9.517298617381897;133.46855707074621;6.518977089658987;0.004467072491254967;0.7296214167088868;[TGFB1, CR1, LILRB2, HLA-G, LILRB4, DUSP10, BCL6, IFNG, FANCD2, IL2RA, CD28, CTLA4]
GO:1904798;positive regulation of core promoter binding;7.0;1.0;0.8509193652572005;9.628524252492122;62.59990527316089;7.9853141584524145;0.002095162493235609;0.7592887026755414;[IFNG, KLF4]
GO:0045348;positive regulation of MHC class II biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;147.28763043943843;7.9853141584524145;0.0049295844405465;0.7592887026755414;[IL10, CIITA, AZU1, SIRT1]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[SPI1, EHMT2, SLA2, MYB, HOXA2, HOXA7, JUNB, MEF2A, MED1, MEF2C, HOXB4, HOXB3, ATF3, NEDD4L, GATA3, GATA1, PRDM16, HESX1, ELANE, JUN, PLK1, FZD8, NR2F2, SNAI2, PKIG, EZH2, BTG2, PAWR, PAX5, SIRT1, AES, MMP12, ZEB1, TAL1, RARA, HCLS1, ASCL2, STAT1, NR1H2, NR1H4, POU4F1, FOSB, TNF, DACH1, MEN1, TLE4, DNMT1, AEBP1, FOXO1, NACC2, WFS1, NFKB1, NFKB2, BCL6, CDK2, CIITA, FHL2, FASLG, FOXM1, HHEX, RFC1, PEG3, CEBPA, CEBPB, HDAC2, UHRF1, RBBP8, E2F1, E2F7, E2F8, PRRX1, KLF4, KLF8, KLF5, DNAJA3, GFI1, UXT, ZNF608, EDNRB, SOX7, SOX4, HNF1B, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H2, SUV39H1, BMI1, XPO1, CD36, HBZ, EDN1, PARP9, IL1B, SP100, SATB2, RELB, RXRA, APBB1, CDX2, LILRB4, NEDD4, LOXL2, CHCHD3, EOMES, CCNE1, TIMELESS, TCF7, TGFB1, CBX4, VDR, CAV1, NR4A2, BMP2, NR4A3, MXD1, MYOCD, KLF12, IFNG, IRF7, IRF8, FBP1, LEF1, AURKB, TBX21, SNCA, MEIS2]
GO:0045471;response to ethanol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;69.73224034292265;5.006389003214805;0.0023338753293357085;0.5462679783062231;[CSF3, SPI1, SPARC, TNC, ICAM1, EEF1B2, ALAD, PRKCE, CYBB, ADCYAP1, CLDN3, IL1B, CLDN7, RARA, S100A8, BIRC2, PSMD14, FECH, GATA3, TYMS, CCL7, CNR1, FYN, CD14, GSN, VCAM1, GGH, RPS6KB1, CDK1, CD27]
GO:0097421;liver regeneration;6.0;1.0;0.8231203125901445;9.628524252492122;47.21654787453615;6.250713103064308;0.0015802953652264606;0.6427820713687392;[IL10, CEBPB, PCNA, TGFB1, IHH, TYMS, SULF2, AURKA, NFKBIA, HMOX1, EZH2]
GO:0032868;response to insulin;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;74.03337757263446;4.800339885259895;0.0024778305216419678;0.5964089702280253;[CYFIP1, ADM, ICAM1, SESN3, AKT1, IL10, GHSR, CAD, SIRT1, CEACAM1, RAB31, TLR2, PRKDC, RETN, FOXO1, PAK1, PLN, LYN, EGR1, EGR2, SORT1, STAT1, GGH, SORBS1, RPS6KB1]
GO:0032747;positive regulation of interleukin-23 production;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;64.94897299966192;8.16763571524637;0.0021737836760178982;0.7408135829017477;[CSF2, IFNG, MYD88, IL17A]
GO:0010835;regulation of protein ADP-ribosylation;8.0;0.9326813400603323;0.8413406700301662;9.548481544818586;75.95246883248204;7.57984905034425;0.0025420607790390634;0.7626338329336335;[IFNG]
GO:0048863;stem cell differentiation;4.0;0.7043150770688792;0.6021575385344395;8.242229891372231;21.066225782797595;5.734022359845919;7.050676185779127E-4;0.5432381701418294;[HHEX, EPCAM, FRZB, HOXA7, A2M, EOMES, MEF2C, TGFB2, ACE, LIF, HNF1B, RUNX2, PAX2, LIN28A, TAL1, KIT, HOXB4]
GO:0048861;leukemia inhibitory factor signaling pathway;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;28.111912685638995;8.390779266560578;9.408804185094754E-4;0.7800242071602487;[LIF]
GO:0032740;positive regulation of interleukin-17 production;6.0;0.8653626801206646;0.7558016526504768;9.427853557029971;65.23665507211369;7.212124270218933;0.002183412136085803;0.6919486831672181;[TGFB1, IL23A, IL15, IL18, PRKCQ, NOD2, LY9, MYD88]
GO:0070301;cellular response to hydrogen peroxide;6.0;1.0;0.8231203125901445;9.628524252492122;361.02555909653125;5.682729065458369;0.012083200561052132;0.6137353412716126;[HDAC2, PCNA, TNFAIP3, ETS1, FOXO1, AQP1, CST3, IL18RAP, PDGFD, MYB, CYP1B1, ECT2, ANXA1, ARG1, PRKCD, KLF4, SIRT1, PAX2, MAPK13, FABP1, IL6, CDK1, EZH2]
GO:2000330;positive regulation of T-helper 17 cell lineage commitment;14.0;1.0;0.9759193652572005;9.628524252492122;3030.274946811922;8.390779266560578;0.10142057539939929;0.9050242071602486;[IL23A, IL12RB1]
GO:0050829;defense response to Gram-negative bacterium;7.0;1.0;0.8509193652572005;9.628524252492122;71.44439831434403;5.407625775213448;0.0023911797157970473;0.627465598881932;[IGHM, HIST1H2BK, SERPINE1, HMGB2, PYCARD, CTSG, IL6R, CAMP, DEFA4, SLC11A1, RNASE6, RNASE3, AZU1, DEFA1, LYZ, SELP, CD4, IL6, IL23A, BPI, TLR4, LTF]
GO:0045918;negative regulation of cytolysis;5.0;0.8259837884571596;0.7032329060895001;9.377209824211215;41.247147119458;8.390779266560578;0.0013805048940658876;0.7193458537639684;[CSF2, PAX2, PF4]
GO:0045599;negative regulation of fat cell differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.62387697121986;5.948432231191374;0.0038363580074348307;0.6273234135236593;[TGFB1I1, RORA, GATA3, TNF, FOXO1, E2F1, TGFB1, JAG1, SORT1, SIRT1, IL6]
GO:0045355;negative regulation of interferon-alpha biosynthetic process;8.0;1.0;0.875;9.628524252492122;856.9810707607687;9.083926447120524;0.028682385205471922;0.839552420951524;[IL10]
GO:0002664;regulation of T cell tolerance induction;6.0;0.7586651285174919;0.7024528768488905;9.223059144383958;40.47435082521816;7.474488534686424;0.0013546400975691913;0.7053660038532718;[IL2RA, CLC, LILRB2, CD3E, HLA-G]
GO:0032735;positive regulation of interleukin-12 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.311337724880743;0.002183412136085803;0.6458824173477649;[CD40, HSPD1, CCR7, CD36, CCL19, RIPK2, MAPK14, HLA-G, CD40LG, IFNG, IL23A, IRF8, LTB, PLCB1, TLR4, TLR2]
GO:0002548;monocyte chemotaxis;7.0;1.0;0.8509193652572005;9.628524252492122;125.46101547564297;6.039404009397101;0.004199067280386423;0.6597747671587765;[CCL13, CCL23, CALCA, ANXA1, CCL21, CCL20, TNFRSF11A, LGALS3, IL6, CCL8, CCL7, CCL5, CCL4, XCL2, TNFSF11, CCL2, XCL1, S100A12, CCL1, CCL19, CCL18, IL6R, CCR2]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[SERPINE1, PHB2, AKT1, PROK2, IER3, MED1, MEF2C, PRKCH, DAPK1, PRKCD, CLDN7, PRKCQ, PRKDC, GATA3, SLC30A10, GATA1, PRKCZ, FIGNL1, HMOX1, SFN, NCKAP1L, BARD1, JUN, PLK2, PLK1, EIF2AK2, AZU1, SNAI2, CDKN1A, BTG2, CHL1, TIMP1, JAK3, ANXA1, SERPINB2, DUSP1, RIPK2, ANXA5, SERPINB9, SIRT1, PAX2, RARA, HCLS1, PTGS2, UNG, NTF3, FLNA, CCL19, CCL21, GABRA5, NR1H4, POU4F1, FABP1, PF4, CSF2, TNF, CLU, LAMP3, CLEC5A, F2R, ADCYAP1, MSH2, ADAM8, CSF1R, BLM, DNMT1, CORO1A, FOXO1, SOCS2, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, DAB2, CXCL12, COPS5, BCL6, BCL3, CDK1, BCL2, MYD88, BCL2L1, LRRK2, FHL2, FASLG, ARRB1, ARRB2, CYR61, GPX1, TNFRSF1B, ADAMTS20, BIRC5, BIRC2, BIRC3, CX3CR1, CEBPB, HDAC2, LRP1, NLRC4, NOD2, CCL5, CCL2, FYN, TIE1, KLF4, IL2RB, EVI2B, IL1RN, SLC46A2, IFIT3, AQP1, ICAM1, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB2, EPHB1, FLT3LG, HNF1B, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, TWIST1, PKHD1, EGR3, BCL11B, TNFSF14, IGF1, PTK2, VNN1, ID1, CD28, CD27, NRP1, KIF14, BRCA1, CTSH, CD38, CCR7, CCR5, IL10, EDN1, FCER1G, STRADB, HCK, RNF144B, IL1A, CEACAM6, IL1B, CEACAM5, KIT, YAP1, IFI6, AIF1, GNAI2, CXCR2, PDPN, CTNNA1, CD74, LILRB1, CD40LG, GRINA, MAD2L1, ZFAND6, IHH, MPO, COMP, ARHGDIA, PDGFRB, GHSR, PDGFRA, C5AR1, PSEN2, ALOX12, STIL, CBX4, CAV1, NR4A2, NFKBIA, VIL1, IL6, NR4A3, NAT8, IL7R, TNFAIP8, HMGB2, SLC40A1, TNFAIP3, NUP62, CASP2, MYOCD, PLAUR, MMP9, GREM1, NDUFS3, IRF7, ZMYND11, LTF, BCL2A1, TAF9, LEF1, DLL1, THBS1, AURKB, HSPD1, AURKA, SNCA, SOD2, RPS6KB1, TEK, NAA15]
GO:0042098;T cell proliferation;6.0;0.7248374789738407;0.6855390520770648;9.081980546124052;51.294476028837884;6.343086423195323;0.0017167799506538708;0.647506047256038;[CD151, EBI3, FYN, TNFSF14, RIPK2, IL15, SLC11A1, LILRB1, IL23A, FKBP1B, DOCK2]
GO:0034116;positive regulation of heterotypic cell-cell adhesion;6.0;1.0;0.8231203125901445;9.628524252492122;52.08961109106789;7.212124270218933;0.001743392405611612;0.6919486831672181;[IL10, CEACAM6, IL1B, THY1, TNF]
GO:0034115;negative regulation of heterotypic cell-cell adhesion;8.0;1.0;0.875;9.628524252492122;130.132988179366;7.57984905034425;0.004355434002277579;0.7626338329336335;[IL10, IL1RN, KLF4]
GO:0032733;positive regulation of interleukin-10 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.375876246018314;0.002183412136085803;0.6491829203200885;[CD274, CD83, FCER1G, NOD2, PRKCZ, HSPD1, PYCARD, CD40LG, IL23A, BCL3, CD28, XCL1, TIGIT, TLR4, CD34, TLR2]
